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Abstract  
 
Human lysozyme (HuL) is a widely characterised protein whose mutational variants misfold, 
forming amyloid fibrils that are associated with a rare systemic amyloidosis. Given that a 
number of proteins, including lysozyme, can misfold and give rise to disorders such as 
Alzheimer’s disease, Parkinson’s disease, and type II diabetes, it is vital to understand the 
mechanistic features by which this process occurs, in order to attempt to cure or regulate these 
diseases. Work on lysozyme and other globular proteins has revealed that they require a process 
of global or partial unfolding to initiate protein aggregation, which is different from the natively 
unfolded proteins known as intrinsically disordered proteins (IDPs). Although the processes of 
folding and fibril formation for HuL have been well studied, the details of the early events 
leading to aggregation have proven difficult to study. Recent advances in site-specific labelling 
of HuL have made it possible to introduce Alexa fluorophores into the I59T variant of HuL 
without perturbing the process of in vitro fibril formation as compared to the unlabelled protein. 
Using this fluorescently labelled protein, we have used single-molecule fluorescence 
microscopy techniques including two-colour coincidence detection (TCCD) and fluorescence 
resonance energy transfer (FRET) to determine the oligomer population distributions present 
during the aggregation of HuL. Our data showed that HuL populates disordered small low-
FRET oligomers (<10 monomers) which in turn can undergo a conformational change to form 
more stable and structured high-FRET oligomers over the course of the aggregation. The 
second type of oligomers can then grow to form amyloid fibrils. We fitted our data from the 
early stages of the aggregation reaction to an early-time kinetic model, in which the monomer 
concentration can be assumed constant during the selected period of time. Using this model, 
we calculated the different rate constants associated with the microscopic steps along the 
aggregation pathway that we were able to monitor using SM techniques. In addition, the 
interactions between HuL oligomers and the extracellular chaperone clusterin were 
investigated. Previous studies have shown that clusterin inhibits I59T HuL aggregation by 
interacting with species formed early in the aggregation pathway. Here, we show that clusterin 
enhances the population of small high-FRET oligomers, trapping them and preventing their 
growth into larger aggregates over the time-course of our analysis. These results allow us to 
directly compare the mechanism of protein aggregation in a globular system versus that of 
IDPs, providing potential insight into targeting these pathways for therapeutic interventions.
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Chapter 1: Introduction  
 
1.1. Protein aggregation and disease 
 
1.1.1. Misfolding diseases and their connection to protein aggregation 
 
A substantial number of commonly known medical conditions such as Alzheimer’s and 
Parkinson’s diseases are characterised by the presence of insoluble amyloid fibrils and their 
deposition in the brain, but also in different parts of the body [1]. These disorders are identified 
as ‘deposition diseases’, and can be grouped into three main categories; neurodegenerative 
diseases which affect neuronal cells, non-neuropathic systemic diseases that involved multiple 
organs and localised amyloidosis where aggregates are observed in a single organ [2]. Some of 
the more common diseases and the proteins associated with aggregation are listed in Table 1. 
The interest in these diseases has exponentially increased as the number of affected individuals 
is rapidly rising [3, 4]. The ageing population possess a higher probability of suffering from 
one of these deposition diseases, likely because a decrease in the efficiency of the mechanisms 
that maintain proteins in their functional states occurs with age [5]. 
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Table 1. Human diseases associated with protein aggregation. Adapted from reference [2]. 
Disease 
Aggregating 
protein or peptide 
Number of residues 
Native structure of 
protein or peptide 
 Neurodegenerative disorders 
Alzheimer’s disease Amyloid-β peptide 37-43 
Intrinsically 
disordered (ID) 
Amyotrophic lateral 
sclerosis 
Superoxide 
dismutase 1 and 
TDP-43 
153 and 4114 β-sheet and Ig-like 
Huntington’s 
disease 
Huntingtin 
fragments 
Variable Mostly ID 
Parkinson’s disease α-synuclein 140 ID 
Spongiform 
encephalopathies 
Prion protein or its 
fragments 
230 ID and α helical 
 Non-neuropathic systemic amyloidosis 
Amyloid light chain 
(AL) amyloidosis 
Immunoglobulin 
(Ig) light chains or 
its fragments 
∼ 90 β-sheet and Ig-like 
Amyloid A (AA) 
amyloidosis 
Serum amyloid A1 
protein fragments 
76-104 
α-helical and 
unknown fold 
Hemodialysis-
related amyloidosis 
β2-microglobulin 99 β-sheet and Ig-like 
Lysozyme 
amyloidosis 
Lysozyme variants 130 α-helical and β-sheet 
Senile systemic 
amyloidosis 
Wild-type 
transthyretin 
127 β-sheet 
 Non-neuropathic localised amyloidosis 
Cataracts γ-Crystallins Variable 
All β- and γ- 
crystallin-like 
Injection-localised 
amyloidosis 
Insulin 21 and 30 
α-helical and 
insulin-like 
Type II diabetes Amylin 37 ID 
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1.1.2. Protein misfolding and the misfolding landscape 
 
In recent years, a great effort has been placed on characterising the free-energy landscape of 
proteins in order to understand their folding and misfolding processes [6, 7]. The energy 
landscape is a statistical description of the potential surface of a protein, from the unfolded 
state to the folded native-state, the latter representing a minimum in a rugged, funnel-like 
landscape that includes several folding intermediates with different structures. More recently, 
this concept has been expanded to include the energy landscape of intermolecular interactions 
leading to aggregates and other possible states [8]. Figure 1.1 shows an energy landscape 
diagram of a protein where folding processes are represented in purple and aggregation 
processes are in pink. The folding processes involve intramolecular contacts within a protein; 
initially, the unfolded ensemble represents a wide population of high energy states that can be 
present in a multitude of conformations, which sample more compact structures via 
intramolecular interactions, leading to folding intermediates, partially-folded states and finally, 
the native-state [9]. The aggregation pathway involves intermolecular contacts between protein 
molecules, such as partially-folded states which can lead to oligomers but also amorphous 
aggregates and amyloid fibrils, which are thermodynamically stable and correspond to energy 
minima on this pathway [7, 8, 10, 11]; therefore, given that they are less thermodynamically 
favourable, the folding events leading to the native-state are kinetically driven [12]. 
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Figure 1.1. Energy landscapes of protein folding and aggregation. The purple region on the 
left represents the conformational states that are populated during folding processes in order to 
reach the native-state. These conformations are formed by intramolecular interactions. The 
pink region on the right represents the conformational states present in the aggregation 
processes, where the interactions are intermolecular, and the amyloid fibrils represent the more 
thermodynamically stable state. Adapted with permission from reference [9].  
 
1.1.3. Amyloid fibrils 
 
Amyloid fibrils are proteinaceous deposits which can be formed from a diverse range of 
proteins, independent of their native structure or primary sequence. Amyloid fibrils display a 
number of common attributes including birefringence when binding Congo red dye and 
increased fluorescence upon binding to Thioflavin-T. Structurally, they possess a high degree 
of β-sheet content with a common cross-β structure and their morphology appears as long and 
unbranched strands, up to microns in length with a diameter of a few nanometres [13, 14]. 
These amyloid fibrils can be negatively stained, i.e. the background can be stained with a dye 
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such as uranyl acetate, and observed by electron microscopy (Figure 1.2). Although these 
structures were first related to a range of disease-associated proteins, amyloid fibrils are now 
described as an alternative state that may be accessible to all proteins [1, 5, 15]. 
 
 
Figure 1.2. Structural features of amyloid fibrils. a) Solid-state NMR-based structural model 
of protein fibrils with an interstrand spacing of 4.7 Å and an intersheet spacing of 10 Å (adapted 
with permission from reference [16]). b) Solid-state NMR atomic resolution structure of 
amyloid fibrils (centre) and a close up image (right). An electron microscopy image is shown 
on the left (reproduced with permission from reference [17]).  
 
1.1.4. Mechanisms of protein fibril formation 
 
Whilst protein folding is highly dependent on the amino acid sequence, protein aggregation is 
thought to have its origins in the polypeptide chain behaviour, which makes the protein act as 
a typical polymer with the main chain amide-groups forming crucial intermolecular hydrogen 
bonds [18]. This process is dependent on environmental conditions such as pH, temperature, 
and the presence of other molecules. Independent of the solution conditions, fibril formation 
can be generalised as having a lag phase where nucleation takes place, an elongation process 
representing the rapid growth of the fibrils, and a final plateau where mature amyloid fibrils 
are formed (Figure 1.3, a) [19]. Recent research has developed a more detailed analysis of the 
kinetic processes involved during amyloid fibril formation [20-24]. The analyses of precisely 
controlled aggregation experiments are able to identify the events occurring during the 
formation of the amyloid fibrils; whether this is through primary nucleation, where aggregate 
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formation is dependent on the monomer concentration, or through secondary events, such as 
monomer-independent fragmentation or monomer-dependent secondary nucleation (i.e. 
nucleation of new aggregates is catalysed by available sites on existing fibrils) (Figure 1.3, b-
e) [20, 25, 26]. This kinetic analysis approach has shed light on the aggregation process of a 
number of systems, including amyloid-β [25, 27], α-synuclein [28, 29], the yeast prion protein 
Ure2 [30], tau [31-33], and hen egg-white lysozyme (HEWL) [34], and it has been used to 
identify how small molecules [35-38] and biomolecules such as chaperones and antibodies [39-
41] can modulate these events. Although an incredibly powerful tool, this analysis generally 
requires specific in vitro aggregation conditions, in particular the use of quiescent conditions, 
which limits its application as these are not experimentally amenable to all protein systems.  
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Figure 1.3. Schematic of the different species and processes generally involved in protein 
fibril formation. a) Different phases along the fibril forming pathway as followed by ThT 
fluorescence, which is proportional to the fraction of fibrils. The lag phase, elongation and 
plateau or equilibrium phase are shown in blue, orange and green, respectively. Below, the 
typical species found during these phases are shown in the same colours. Monomers are shown 
as circles, oligomers are shown as four circles assembled together and fibrils are shown as a 
series of rounded squares. Note that the proportion of oligomers is always low regardless of 
the phase. This is generally the case in the literature [8, 29-31, 42-44]. b), c), d) and e) 
Schematics of the defined kinetic processes occurring during protein fibril formation. b) 
Primary nucleation and its corresponding rate of formation (kn). c) Elongation (k+) and 
dissociation (koff). d) Fragmentation (k-). e) Monomer-dependent secondary nucleation (k2). 
Modified from reference [26]. 
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1.2. Human lysozyme fibril formation and its connection to disease 
 
1.2.1. Human lysozyme and systemic amyloidosis 
 
Discovered by Alexander Fleming in 1922, human lysozyme (HuL) is an antibacterial enzyme 
that functions by degrading bacterial cell walls and is found in a number of human secretions 
including tears, saliva and human milk [45]. Human lysozyme belongs to the group of 
lysozymes defined as chicken or conventional type (c-type) lysozymes [46]. Among the c-type 
lysozymes, HEWL has been especially useful in the study of enzymatic mechanisms after its 
structure was defined by X-ray crystallography [47]. Human lysozyme is a globular 130-
residue protein which contains four disulphide bridges and two domains: the α-domain 
(including residues 1-38, and 86-130), which contains four α-helices (A, B, C, and D), and the 
β-domain (residues 39-85), which mostly contains β-sheet structure [47-49]. The X-ray 
structure of wild-type human lysozyme (WT HuL) is shown in Figure 1.4. 
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Figure 1.4. Schematic representation of HuL X-ray structure. The β-domain and the α-
domain are labelled in the upper and lower portion of the picture, respectively. The naturally 
occurring mutations and their locations within HuL are highlighted on the structure of WT HuL 
(PDB entry 1JSF). These are Y54N (blue), I56T (light green), F57I (pink), W64R (orange), 
D67H (dark green), T70N (black), W112R (cyan), and L102S (red). In addition, two double 
mutations have been linked with disease; F57I/T70N and T70N/W112R. The four disulphide 
bonds are shown in yellow. The four α-helices are labelled A-D. The structure was produced 
using PyMOL (PyMOL, Molecular Graphics System, Version 1.7.4 Schrödinger, LLC).  
 
Human lysozyme was first linked to disease in 1993, when the I56T and D67H point mutations 
were discovered to be the cause of hereditary systemic amyloidosis [50]. The patients showed 
large amounts of fibril deposits in their visceral organs including the liver, kidneys and spleen 
(Figure 1.5) [51]. Further analysis of the ex vivo deposits showed that the fibrils consisted solely 
of variant protein and that these deposits shared common features of amyloid fibrils [48, 50, 
51]. Although the cause of lysozyme fibril formation in vivo remains unknown, it is likely 
related to two main reasons: first, the amyloidogenic variants show an increased ability to 
fluctuate to the transient intermediate state (section 1.2.2), which allows these variants to more 
readily nucleate and aggregate over time. Second, the amyloidogenic variants are likely 
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escaping the protein quality control mechanisms in patients somehow, since only 
amyloidogenic variants are found in the masses of fibrils. These mechanisms are responsible 
for clearing unfolded proteins from the body and do not do so in these patients, whereas these 
variants are cleared by healthy organisms such as yeast, the human cell line HEK293, and 
Drosophila melanogaster [63-66]. 
 
 
Figure 1.5. Deposition of variant lysozyme in a patient suffering from systemic 
amyloidosis. Scintigraphic images of post-mortem fibril deposits found in several visceral 
organs (kidneys, spleen and liver) of an affected individual (a) compared to a normal patient 
(b). Adapted with permission from reference [51]. 
 
After the discovery of the I56T and the D67H variants, five other naturally occurring disease-
related mutations (Y54N, F57I, F57I/T70N, W64R, L102S and T70N/W112R) were identified, 
along with two variants (T70N and W112R), which are not disease-associated on their own 
(Figure 1.4) [52-57]. In order to understand the consequences of the mutations on the folding 
and misfolding processes of human lysozyme, previous studies characterised the I56T and 
D67H variants by using different biophysical techniques and showed that these variants possess 
lower native-state stabilities compared to WT HuL [58, 59]. X-ray crystallography and NMR 
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analysis have shown that the mutations introduce structural changes to the interface region 
between the α- and β-domains [60]. The unfolding of the two amyloidogenic variants occurs 
in a less cooperative process than WT HuL and this results in partly unfolded intermediate 
states being significantly populated, in which the β-domain and the C-helix are significantly 
unfolded whereas the rest of the protein maintains the native-like conformation [48]. This 
reduction in global cooperativity is not unique to the amyloidogenic variants as WT HuL and 
the non-disease related T70N variant can also populate the partially-unfolded intermediates 
under destabilising conditions [58, 61, 62]. Though much research has been done on the 
naturally occurring HuL variants, the main limitation to their study is their low expression yield 
in recombinant protein expression systems. This has been extensively studied in the yeast, 
Pichia pastoris, which demonstrated that there is a relationship between the expression yield 
of different variants of human lysozyme and their native-state stability, with the less stable 
variants causing an upregulation in the quality control mechanisms within Pichia pastoris and 
resulting in the degradation of these proteins [63, 64]. Interestingly, this stringent quality 
control mechanism, resulting in lower expression levels of amyloidogenic variants, was also 
identified when these proteins were over-expressed in Drosophila melanogaster and the 
mammalian cell line, HEK293 [65, 66]. To alleviate the issues with protein expression, a non-
natural variant (I59T) is used for many structural studies as this variant was found to possess 
the amyloidogenic properties displayed by the naturally occurring I56T variant, albeit showing 
a native-state stability which lies between that of the latter and WT HuL [67]. The higher 
native-state stability results in a higher expression yield than the amyloidogenic variants and 
therefore makes I59T HuL an ideal model for the study of lysozyme amyloidosis [63, 67].  
 
1.2.2. The mechanisms of unfolding and fibril formation of human lysozyme 
 
Since being linked to systemic amyloidosis, the unfolding and aggregation of amyloidogenic 
variants of HuL have been extensively investigated [48, 68, 69]. Like other globular proteins, 
human lysozyme locally unfolds to initiate aggregation [70]. The presence of an unfolding 
intermediate was initially characterised using hydrogen-deuterium exchange mass 
spectrometry (HDX) experiments by Canet and co-workers in 2002 [58]. HDX allows for two 
types of processes to be observed: type 1 (EX1), which occurs when the rate of exchange of 
deuterium for hydrogen of the transient partially-unfolded intermediate is faster than its closing 
rate to the folded native-state; and type 2 (EX2), which occurs when the closing rate is faster 
than the exchange rate [71, 72]. Under EX1 conditions, and using physiologically relevant 
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conditions, EX2 was detected for both WT HuL and the variants whereas EX1, which 
corresponds to the presence of a transient partially-unfolded intermediate, was only detected in 
the case of the variants, D67H and I56T (Figure 1.6, a). Recently the ability of the D67H variant 
to form this transient partially-unfolded intermediate was shown to be reduced in the presence 
of a camelid nanobody, cAb-HuL6, resulting in the inhibition of fibril formation [73]. This 
study therefore showed that the formation of this intermediate is a crucial step for lysozyme 
fibril formation [73] (Figure 1.6, b). This transient intermediate is extremely lowly populated; 
however, under acidic conditions it is possible to populate a molten globular state to a high 
enough percentage to use 2D NMR techniques to explore its structural attributes. In 2010, 
Dhulesia and co-workers used a range of biophysical techniques including differential scanning 
calorimetry and NMR to demonstrate that, under amyloid forming conditions, the intermediate 
species of the I59T and I56T variants appear to be an ensemble of interconverting conformers 
with varying degrees of denaturation [74]. Most recently, the intermolecular interactions 
between the partially-unfolded intermediate species of the I59T variant, which are believed to 
give rise to fibril formation, were studied using paramagnetic relaxation enhancement (PRE) 
measured by NMR [75]. This study demonstrated that the initial interactions leading to fibril 
formation most likely occur between residues within the unfolded β-domain [75].  
 
 
Figure 1.6. Unfolding dynamics of HuL as detected by HDX experiments. a) Electrospray 
mass spectra of WT and D67H HuL after exposure to HDX conditions (37 °C, pH 8.0). For 
D67H HuL, local unfolding events give rise to the peaks coloured in yellow (EX1) whereas the 
peaks coloured in red arise from EX2. The peaks in green and black are the control samples 
recorded for time zero and time infinity, respectively. Reproduced with permission from 
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reference [58]. b) Electrospray mass spectra of D67H lysozyme in the presence of an equimolar 
amount of the camelid nanobody, cAb-HuL6. The local unfolding events shown in (a) for 
D67H HuL (yellow peaks) are not detected in the presence of the nanobody. The peaks 
coloured in green arise from EX2. The peak in black was observed from a control sample 
recorded after complete hydrogen–deuterium exchange. Adapted with permission from 
reference [73]. 
 
In addition to the formation of a partially-unfolded intermediate, previous studies have shown 
that as native-state stability decreases for HuL variants, faster rates of aggregation are achieved 
[76]. However, native-state stability is not the only factor determining the aggregation 
dynamics as the location of the mutations also plays a crucial role in determining the rate of 
the population of the intermediate state which in turn will favour amyloid formation [77]. 
Mutations located in the β-domain, which is the region predominantly unfolded when the 
transient intermediate is formed, have a higher ability to populate the intermediate than those 
situated in the α-domain [77]. Interestingly, as shown in Figure 1.4, all the naturally occurring 
mutations happen to be located in the β-domain or at the interface between the two domains. 
In addition to the presence of the transient intermediate, in vitro fibril formation of HuL shows 
a notable seeding effect [62], which suggests that the aggregation follows a nucleation-
dependent mechanism (Figure 1.7). In parallel to the study of the aggregation mechanism, its 
inhibition has also been investigated extensively. A series of camelid antibodies was shown to 
prevent the formation of these partially-unfolded species by restoring the global stability of 
different HuL variants and hence stopping aggregation [73, 78], and the extracellular 
chaperones clusterin, haptoglobin and α2-macroglobulin (α2M) have been shown to inhibit 
lysozyme amyloid formation by interacting with pre-fibrillar species in the early stages of the 
aggregation process [69, 79]. 
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Figure 1.7. Proposed mechanism of aggregation of HuL. The monomeric native-state can 
partially unfold to populate a transient intermediate that results from the reduction in 
cooperativity shown by human lysozyme variants in combination with decreased native 
stability. This intermediate is also in equilibrium with the unfolded state. The unfolded β-sheet 
domains of the intermediates are likely the first point of contact leading to the formation of 
oligomeric-like species (which have not yet been structurally characterised in the literature) 
before forming amyloid fibrils. Modified from reference [69]. 
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As mentioned above, globular proteins must undergo local and/or global unfolding before they 
can start forming amyloid fibrils. One of such proteins is wild-type β2-microglobulin, which is 
related to dialysis-related amyloidosis. β2-microglobulin, like human lysozyme, requires the 
population of an intermediate state, in which aggregation-prone sequences are exposed, in 
order to form fibrils. This kinetically trapped intermediate displays native-like secondary 
structure and has been shown to interact with pre-formed fibrils and promote elongation [201]. 
This intermediate also shows increased conformational dynamics which allow for the 
formation of a rarely populated species that, under certain conditions, enables the formation of 
oligomeric species [202]. This ability of wild-type β2-microglobulin to form amyloid fibrils is 
believed to be catalysed by the presence of the truncated variant ΔN6, in which β2-
microglobulin is truncated at Lys6, which is present in ex vivo amyloid deposits in significant 
proportions (~26%), and can both assemble into oligomers leading to fibril formation and 
increase the ability of the wild-type protein to aggregate into amyloid fibrils in a prion-like 
manner [203]. A wide variety of single amino acid mutations have been proved to change β2-
microglobulin’s propensity to aggregate by changing its conformational dynamics in a similar 
way to lysozyme mutants [202, 204, 205]. Using mass spectrometry and analytical 
ultracentrifugation, Smith and co-workers were able to show that β2-microglobulin forms small 
oligomers (dimers to tetramers) in the early stages if fibril formation [206]. These oligomers 
then undergo conformational changes to form more stable, less dynamic structures in order to 
form fibrils [206. 207]. In addition, the naturally occurring D76N mutant of β2-microglobulin 
is related to a rare form of familial systemic amyloidosis and is found only as the full-length 
protein in the amyloid deposits in patients, which are found in visceral organs, whereas the 
deposits of wild-type protein are found mostly in bones and ligaments. This mutation causes a 
destabilisation of the protein structure that enhances its ability to populate the amyloid-prone 
intermediate [205, 208].  
Transthyretin is a homotetrameric protein that is associated with senile systemic amyloidosis, 
familial amyloid polyneuropathy, and familial amyloid cardiomyopathy. This tetrameric 
protein can dissociate into unstable monomers that then undergo oligomerisation by 
intermolecular interactions and finally form fibrils [209]. The dissociation of the tetramer is 
believed to be generally caused by genetic disposition, i.e. mutations [210, 211]. This belief is 
reinforced by transthyretin mutants being found in the aggregate deposits in patients [212]. 
Regarding the mechanism of transthyretin aggregation, recent research showed that small 
oligomers (5-10 monomers) are formed in the early stages of fibril formation [213]. Research 
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on these small oligomers showed that they are more cytotoxic than fibrils when added to human 
neuroblastoma cells [214], which is in agreement with previous research by Reixach and co-
workers where they showed that either monomeric transthyretin or very small oligomers 
formed in the early stages of aggregation were the major cytotoxic species towards human 
neuroblastoma cells [215]. These studies are also in agreement with research on the same cell 
line by Sörgjerd and co-workers, even though the latter found that the early oligomers were 
formed by an average of 20-30 monomers [216]. These oligomeric non-fibrillar aggregates 
have also been related to the early stages of the disease in vivo for human patients [217, 218] 
and mice [218, 219]. 
The tetrameric form of transthyretin can be stabilised by clusterin under acidic conditions, 
inhibiting its dissociation into monomers, and in turn fibril formation [220]. In addition, 
Clusterin co-localises with non-fibrillar and fibrillar transthyretin in ex vivo deposits [212], its 
expression is increased in transgenic mice for human transthyretin mutant V30M, and its 
expression and secretion are enhanced in human neuroblastoma cells [221]. In addition, the 
same study showed that clusterin binds extracellular oligomeric aggregates and inhibits fibril 
formation, probably through the stabilisation of said early aggregates [221].  In 2015, Greene 
and co-workers showed that clusterin indeed interacts with monomeric and oligomeric 
transthyretin under acid stress in vitro, stabilising both species and preventing fibril formation 
[209]. Figure 1.8 shows the mechanism of aggregation of transthyretin and how it can 
modulated by clusterin, as proposed in reference [209].   
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Figure 1.8. Proposed mechanism of aggregation of transthyretin and its inhibition by 
clusterin. The tetrameric structure of transthyretin can dissociate into monomers, which can 
then unfold and initiate oligomerisation, leading to amyloid fibril formation. Clusterin can 
interact with monomeric transthyretin, as well as with high molecular weight (HMW) 
oligomers, inhibiting aggregation. These interactions proceed in a cooperative manner in the 
presence of diflunisal, a small molecule drug used to stabilise transthyretin tetramers. Figure 
modified with permission from reference [209].   
 
The pharmacological solution for transthyretin aggregation in patients has been proved by 
different approaches. These approaches are: the modulation of the heat shock response via 
regulation of extracellular chaperones, such as Hsp70 and clusterin, which was investigated to 
show that they are involved in the clearance of non-folded transthyretin in vivo [212, 221, 222]; 
small molecules, amongst which doxycycline was approved by the European Medicine Agency 
to be administered in the treatment of familial amyloid cardiomyopathy (EU/3/12/955) [223]; 
and humanised antibodies, which have been found to prevent amyloid formation and deposition 
in mice [224]. The modulation of the aggregation pathway and stabilisation of the transthyretin 
tetramer has also been approached by the use of small molecules such as epigallocatechin 
gallate (EGCG), which is obtained from green tea, and curcumin [225, 226]; both of which 
inhibit transthyretin aggregation by increasing the stability of the tetrameric conformation and 
modulating intermediary species, such as preformed pre-fibrillar aggregates, as well as the 
formation of non-toxic oligomers in the presence of EGCG [225, 226, 227]. Furthermore, 
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curcumin has been found to disaggregate fibrils in mice [228]. In addition to these natural 
compounds, a combination therapy using doxycycline and tauroursodeoxy-cholic acid 
(TUDCA) has been shown to significantly reduce transthyretin deposition and toxic 
aggregates, and clinical trials for this therapy are currently underway in Italy and the USA 
(www.clinicaltrials.gov). Other small molecules and more intrusive therapies, such as liver 
transplantation, are currently being trialled in patients [229].  
 
1.3. Oligomers and their importance in the aggregation pathways 
 
Oligomers are pre-fibrillar species that are present along the aggregation pathway before the 
formation of amyloid fibrils [80]. Although these species are lowly populated, many recent 
studies have found ways to enrich or produce stable oligomers (similar to those found on the 
fibril forming pathway) [81-84], thereby allowing for these species to be better characterised 
using biophysical techniques. Interestingly, oligomers from different protein systems share 
common biophysical attributes such as high levels of exposed hydrophobicity and a spherical 
or sometimes pore-like appearance [81, 85, 86] (Figure 1.9). The structural similarities between 
oligomers from different protein systems was confirmed when the binding of an antibody, 
raised specifically to bind to amyloid-β oligomers, was found to recognise oligomers formed 
by other proteins, successively reducing their toxicity towards cells [87]. This work hence 
demonstrated that the structure and the associated mechanism of pathogenesis for oligomers 
was most likely shared by all protein systems included in that study, independent of primary 
sequence. Oligomers have been found to have a level of cytotoxicity analogous or higher to 
that of amyloid fibrils of disease-related peptides and proteins [18, 87-89] and it is widely 
believed in the literature that the reason for their high toxicity lies in their exposed hydrophobic 
surfaces [87, 89-91]. The potential to prevent the formation of these toxic oligomers or to 
regulate their toxicity, in the context of disease, therefore makes these species a very attractive 
field of research. In fact, the literature shows numerous studies where the inhibition of oligomer 
toxicity is being modulated by using different chaperones [41, 69, 79, 91-95], antibodies [40, 
73, 78, 96, 97] and small molecules [35, 36, 98].   
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Figure 1.9. Oligomers share common biophysical properties. a) ANS fluorescence suggests 
that oligomers are more hydrophobic than amyloid fibrils (reproduced with permission from 
[86]). b) α-Synuclein (αS) oligomers show a pore-like structure (reproduced with permission 
from [81]). c) Oligomers are usually small in size. In the picture, αS oligomers show a broad 
band around 1050 KDa (<10 monomers) (reproduced with permission from [81]). d) Oligomers 
and annular protofibrils as characterised by AFM and electron micrographs (reproduced with 
permission from [85]). e) αS oligomers are more toxic to cells than fibrils as measured by the 
effect on the rate of cytoplasmatic reactive oxygen species (ROS) production (reproduced with 
permission from [81]).  
 
Although much progress in understanding oligomer formation and their role in disease has been 
reported, these pre-fibrillar species are formed, often transiently, at small percentages in 
regards to initial monomer concentration and in highly heterogeneous environments and hence 
are challenging to characterise. Indeed, as mentioned in the section above, the oligomeric 
species formed in the aggregation pathway of HuL have not yet been characterised and it will 
be the objective of this thesis to shed light on their properties.  
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1.4. Single-molecule fluorescence  
 
Unlike ensemble techniques where the data represents the average behaviour of a group of 
molecules, single-molecule (SM) techniques allow for individual molecules to be observed, 
thereby deconvoluting their properties and allowing insight to be gained on different species 
within a large population. This is very important when studying biological systems, where 
often, populations are heterogeneous and some species are lowly populated and therefore their 
study requires this high degree of sensitivity. A wide variety of fluorescence methods have 
been developed in recent years [42, 99-104]. In this section, the fundamentals of fluorescence 
will be covered before addressing the application of SM fluorescence microscopy to studying 
oligomeric species formed during protein aggregation.  
 
1.4.1. Fundamentals of fluorescence 
 
Fluorescence consists of the rapid emission of a photon caused by the relaxation of an electron 
going from an excited singlet state to the ground-state orbital [105]. This emission of a photon 
can be illustrated by the Jablonski diagram (Figure 1.10) as described by Aleksander Jabonski 
in 1933 [106]. In brief, following light absorption, a particular molecule (commonly known as 
fluorophore) can get excited to a higher vibrational level of the excited states (S1 or S2) from 
which it rapidly relaxes to the lowest vibrational level of the first excited state (S1). The 
excitation of the fluorophore occurs in a timescale of 10-15 seconds (s). The process of internal 
relaxation occurs within 10-12 s and it is usually known as internal conversion or vibrational 
relaxation. The return to the ground-state (S0) or the process of fluorescence usually occurs 
within 10-8 s and it is followed by its own internal conversion until a thermal stability is reached. 
As can be observed in the Jablonski diagram, the energy of emission is always lower than the 
energy of absorption i.e. fluorescence emission occurs at longer wavelengths. The difference 
between the wavelength of absorption and that of emission is called Stokes shift [107]. This 
emission of a photon is observable by a detector and this is the basis for fluorescence 
techniques.  
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Figure 1.10. Fundamentals of fluorescence. a) A representative Jablonski diagram. The 
fluorophore gets excited from the ground state (S0) to a higher vibrational level of an excited 
state (S2). Internal conversion to the lowest vibrational level of the first excited state (S1) 
follows before the emission of a photon (fluorescence) and the return to S0. The associated 
timescales for each of the processes have been included. b) Due to internal conversion, 
fluorescence emission will always appear at higher wavelengths than that of excitation. The 
difference between those two wavelengths is known as Stokes shift. Modified from references 
[108, 109].  
 
1.4.2. Fluorophores 
 
Fluorophores are organic molecules that are able to absorb and emit light. If a fluorophore is 
attached to a protein, information can be gathered that may help characterise the protein e.g. 
its location, quantity or structure. The number of emitted photons relative to the number of 
absorbed photons is known as quantum yield (ϕ). The brightness of a fluorophore is 
proportional to the product of its quantum yield and its extinction coefficient i.e. the higher the 
quantum yield of a fluorophore, the brighter it is. The extinction coefficient is given by the 
capacity of the fluorophore to absorb light at a given wavelength and can be calculated using 
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the Lambert-Beer law, in which the absorbance of light equals the extinction coefficient 
multiplied by the concentration of the fluorophore and the distance travelled by the light. A 
fluorophore with a large extinction coefficient will therefore need a lower concentration to 
absorb the same number of photons as a fluorophore with a small extinction coefficient. The 
lifetime of a fluorophore can be described as the average time the fluorophore remains in the 
excited state before going back to the ground-state [108, 109]. 
Hence, the ideal fluorophore will be one that has high quantum yield (number of photons 
emitted per photons absorbed), extinction coefficient (number of photons absorbed at a given 
concentration) and lifetime (time available to gather data from its emission before the 
fluorophore relaxes back to the ground-state) as well as a large Stokes shift so the fluorescence 
emission can be separated from the excitation light.  
 
1.4.3. Alexa fluorophores 
 
In this thesis, the fluorophores Alexa488 (A488) and Alexa647 (A647) were chosen for all the 
SM fluorescence experiments and their molecular structures are shown in Figure 1.11 (a) and 
(b). A488 is excited with blue light while A647 is a red light excited dye, and they have maxima 
of excitation/emission of 494/519 and 651/672 nm, respectively. The reason for this choice of 
fluorophores was based on their wide use in the literature and their superior properties such as 
high extinction coefficients, quantum yields and good photostability and lower self-quenching 
[110]. Quenching can be described as the loss of fluorescence signal due to interactions of the 
fluorophore with its short-range molecular environment e.g. the same fluorophore if there is 
more than one label per monomer. In all experiments within this thesis, only one fluorophore 
will be incorporated per protein molecule and therefore this last property is less relevant than 
the others. Finally, A488 and A647 make a good FRET pair as the emission of A488 overlaps 
well with the excitation spectrum of A647 (Figure 1.11, c). The process of FRET will be 
explained in Section 1.5.3. 
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Figure 1.11. Structure and spectroscopic properties of A488 and A647. a) Alexa Fluor® 
488 NHS ester (Succinimidyl ester). b) Alexa Fluor® 647 NHS ester (Succinimidyl ester). 
Structures drawn in ChemDraw Professional. c) Excitation (blue) and emission (red) spectra 
for A488 and A647. The excitation/emission maxima are 494/519 and 651/672 nm for A488 
and A647, respectively. Adapted from ThermoFisher online product catalogue (items #A20100 
and #A20006).  
  
1.5. Fluorescence microscopy and its application in SM fluorescence 
experiments 
 
Fluorescence microscopy refers to different fluorescence methods in which a microscope is 
used to illuminate and then observe the emitted light from a sample, which is filtered using the 
Stokes shift phenomenon to allow for its separation from the excitation light.  
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1.5.1. Confocal microscopy  
 
Confocal microscopy is a form of fluorescence microscopy in which the volume of the 
observed sample is minimised whilst also minimising the out-of-focus light from the image 
[111, 112]. The latter is achieved by using a pinhole, which is a small circular hole, and a series 
of dichroic mirrors and filters in order to filter the light beam that will reach the detector, 
therefore only allowing the observation of the relevant wavelengths (Figure 1.12). The 
detectors used in the experiments described in this thesis are avalanche photodiode (APD) 
detectors, which are able to detect photons at a nanosecond resolution [113]. Using sub-
nanomolar concentrations in addition to a small sample volume (~1 μm diameter, ~0.5 fL) 
allows for the excitation of only one fluorophore, on average, at any given time [114]. This 
technique uses a bright single point source of excitation, generally a laser, and a sequential 
scanning method which allows for the separation of different fluorophores by optimising for 
the appropriate laser wavelength, and hence eliminating the risk of false positive signals [115]. 
For this thesis, TCCD and FRET are the most relevant confocal microscopy fluorescence 
methods and are explained below.  
 
 
Figure 1.12. Schematic of a confocal microscope set-up. a) The sample is placed on a cover 
slide and is excited with a laser. The fluorescence emission is then passed through a series of 
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lenses, filters and a pinhole to remove out-of-focus light before it is detected by an avalanche 
photodiode (APD) detector. b) Side-view of the confocal volume. Note that the excitation is 
restricted to a small volume (~1 μm diameter, ~0.5 fL). Figure modified from the PhD thesis 
of Dr. Mathew Horrocks.  
 
1.5.2. Two-colour coincidence detection (TCCD) 
 
Two-colour coincidence detection (TCCD) is a SM fluorescence technique that uses confocal 
microscopy to detect coincident events by exciting the sample with two lasers, which provide 
excitation for two different fluorophores. TCCD is very useful for the study of protein 
aggregation as it is a highly sensitive technique that allows for the monomers, for which only 
one burst of fluorescence is observed, to be analysed separately from the oligomers, for which 
coincident bursts from both fluorophores are observed (Figure 1.13) [116, 117]; hence this 
technique has been extensively used to detect and characterise the oligomeric species formed 
during fibril formation of a range of protein systems, including the SH3 domain from bovine 
phosphatidylinositol-3’-kinase (PI3–SH3) [118], amyloid-β (1-40) [119], and the 
polymerisation of neuroserpin [120]. In addition, a study of the interactions of amyloid-β (1-
40) oligomers with the extracellular chaperone, clusterin, demonstrated that this chaperone 
sequesters the oligomers, thus inhibiting fibril formation [41]. TCCD has also been used to 
detect molecular complexes [121], even at femtomolar concentrations [100], to study the 
turnover rate of an enzyme [122, 123], to determine gene activity by counting mRNA 
molecules [124] and to quantify the binding of an antibody to a protein [125].  
 
In order to apply this technique to follow protein aggregation, the protein of interest needs to 
be singly-labelled with one of two different fluorophores whose emission can be distinctly 
separated from one another. The photons emitted by the fluorophores are detected by two 
independent detectors (one for each fluorophore) and only bursts that show higher photon 
counts than an applied threshold will be accounted for. In addition, the ratio of the brightness 
from coincident bursts in each of the channels correlates to the stoichiometric ratio in which 
the dyes are present in the detected complex. In order to analyse the data in an accurate and 
reliable manner, a method was developed in 2006 in the Klenerman Group (University of 
Cambridge, UK) to account for random coincident events which are caused by non-associated 
molecules that simultaneously pass through the confocal volume by chance [100]. 
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Figure 1.13. Schematic of the intensity signal collected during TCCD measurements. 
Oligomeric species (represented with blue and red spheres) will show coincident bursts in both 
the blue and the red channels whilst monomers (represented by only one sphere) will only show 
a burst in the channel corresponding to their respective fluorophore (either blue or red). The 
green dashed lines represent the threshold applied for the analysis.  
 
After applying the appropriate threshold and accounting for the “chance” events, the coincident 
events can be quantified and analysed. This number can then be used to calculate the 
association quotient (Q), which is the fraction of molecules formed by two or more different 
fluorophores as described before [118] using the following equation 
 
Q = 
rS
rB + rR - rS
 = 
rC - rE
rB + rR - rC + rE
  (Eq. 1.1) 
 
where rB and rR are the burst rates detected in the blue and red channels respectively, and rS is 
the significant coincident event rate which is calculated as the subtraction of the expected rate 
of “chance” events (rE) from the total coincident events rate (rC) [118]. The threshold is chosen 
so that it is higher than the background photon count rate, and minimises the rate of chance 
events while maximising that of real coincidence events [126]. In practice, this means selecting 
for a threshold that maximises the association quotient (Q). Although being easy to use when 
all of the species are the same e.g. DNA duplex, this method for choosing a threshold quite 
often provides artificially high thresholds when applied to aggregates since there will be some 
species that are very bright and the Q is maximised when only these are selected. For this 
reason, in this thesis, the threshold was manually selected to maximise the signal-to-noise ratio 
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for each of the dyes and then applied consistently to all the time points throughout the time-
course.  
 
1.5.3. Fluorescence or Förster resonance energy transfer (FRET) 
 
The process of resonance energy transfer (RET) or fluorescence resonance energy transfer 
(FRET) occurs when the emission spectrum of a fluorophore (donor) overlaps with the 
excitation spectrum of another fluorophore (acceptor). FRET results when the excitation of the 
donor is followed by a transfer of energy to the acceptor [127, 128] (Figure 1.14). 
Experimentally, this means only using one wavelength to excite the sample. However, for this 
phenomenon to occur, the donor and acceptor fluorophores must be within 10 nm in proximity 
to each other as the transfer of energy occurs because the donor and acceptor are coupled by 
non-radiative dipole-dipole interactions. The efficiency of the energy transfer is inversely 
proportional to the sixth power of the distance between the molecules. In addition to the 
distance between the fluorophores, the efficiency of the energy transfer depends on the 
dielectric environment, and on the orientation and properties of the dyes. Such properties 
include the overlap of the emission spectrum of the donor with the excitation spectrum of the 
acceptor, and the lifetime and quantum yield of the donor, i.e. the longer the lifetime of the 
donor, the longer the time available to transfer energy to the acceptor, albeit giving more time 
for the fluorescence of the donor itself. The Förster radius or distance refers to the distance 
from the donor dye to the acceptor dye at which the efficiency of the energy transfer is 50% 
and is typically 1-10 nm, which is comparable to the diameter of a standard protein in its 
monomeric state [129]. The Förster radius for the FRET pair formed by A488 and A647 is 56 
Å (as calculated from spectroscopic data by ThermoFisher in The Molecular Probes® 
Handbook). This is important for the work within this thesis because only interacting 
monomers, e.g. oligomers formed during the early stages of fibril formation, will be close 
enough for the fluorophores on the proteins to transfer energy successfully and hence be 
detected. SM FRET has been successfully used in the literature to characterise the structure 
and population distributions of the oligomeric species of different systems [29-31, 33, 42-44] 
as well as to study their interactions with different biomolecules [40, 90, 91, 130]. The use of 
SM FRET to observe and analyse the interactions between oligomers and biomolecules, in this 
case chaperones, will be covered in more depth in Chapter 5.  
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Figure 1.14. Description of SM FRET. a) Jablonski diagram adapted to show FRET. The 
energy transferred from the donor excites the acceptor to an excited state which then returns to 
its ground state as it emits a photon. b) Schematic of the intensity signal collected during SM 
FRET measurements. Oligomeric species that go through the confocal volume (represented 
with blue and red spheres) show coincident bursts in both the donor (blue) and acceptor (red) 
channels whilst monomers (represented by only one sphere) are only detectable in the donor 
channel since only the laser corresponding to the donor is used as the excitation source. The 
green dashed lines represent the applied threshold.  
 
In this thesis, the data from SM FRET was analysed by a well-established method that has been 
explained in detail before [29, 42-44]. In brief, the FRET efficiency for each oligomer was 
calculated using the following equation  
 
EFRET = 
IA
γ × IDA  +  IA
  (Eq. 1.2) 
 
where IA is the intensity of the acceptor, IDA is the intensity of the donor in the presence of the 
acceptor, and γ is a correction factor that can be defined as 
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γ = 
ϕ
A
 × η
A
ϕ
D
 × η
D
  (Eq. 1.3) 
 
where ϕA and ϕD are the quantum yields of the acceptor and donor, respectively, and ηA and ηD 
are the efficiencies for detection of the acceptor and donor photons of the instrument, 
respectively. The apparent size of the oligomer was calculated using the following expression 
 
Sizeapparent=2 × 
IDA + 
IA
γ⁄
ID_monomer
  (Eq. 1.4) 
 
where ID_monomer corresponds to the average intensity of donor monomers. Following the 
analysis from previous studies, species with an apparent size of more than 150-mers were 
excluded from the analysis as the goal was to study only pre-fibrillar species [42, 43].  
 
In summary, whereas FRET registers the interaction of two fluorophores in the same complex 
and hence these must be spatially close enough to present an appropriate spectral overlap, 
TCCD registers events of simultaneous emission by the two fluorophores; and therefore allows 
the fluorophores to be placed anywhere in the molecule. In practice, the high sensitivity of 
TCCD is extremely useful to quantify species and calculate stoichiometries of complexes. On 
the other hand, SM FRET provides extremely useful information about the structure and size 
for individual complexes as well as for an entire population. Although the size of an oligomer 
cannot be directly determined from SM FRET data, an estimation of its apparent size can be 
made and, although not entirely accurate in part because of the different ways that an oligomer 
can pass through the confocal volume and also the stochastic nature of single molecule 
excitation and emission, it can be useful to compare the relative sizes of different oligomer 
populations. In addition, data from TCCD and SM FRET can be mathematically modelled to 
provide further insights into the association and dissociation rates for complexes such as DNA 
[100] and into the mechanism of protein aggregation through the calculation of a number of 
rate constants [29, 42]. This use of SM FRET data will be further explored in Chapter 4.  
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1.5.4. Combining microfluidics with confocal microscopy to use single-molecule 
fluorescence for oligomer characterisation  
 
As established above, using SM microscopy techniques allows for individual molecules to be 
observed and therefore their unique characteristics can be studied.  This is particularly useful 
for studying oligomeric populations as they are usually present in low proportions and have a 
highly heterogeneous nature. The coupling of SM microscopy with microfluidics is currently 
widely applied as the latter allows for the sample to be observed as it flows through a 
microfluidic device, substantially decreasing the time required to collect sufficient events for 
the data to be significant as well as decreasing the background noise [131, 132]. Although it 
would seem tempting to increase the flow rate to minimise time, speed up the collection process 
and maximise the number of events, previous research showed that doing so can actually 
decrease the brightness of the individual bursts until they are no longer detectable [133]. This 
method of fast flow microfluidics coupled with SM fluorescence, optimised in reference [43], 
has been successfully used in the literature [29, 33, 43, 44, 130]. In this thesis, the experimental 
parameters optimised by that study [43] are used to maximise the reliability of the events 
detected while minimising collection time. For this reason, a flow rate of 0.61 cm s-1 was 
chosen for all the SM microscopy experiments. The instrumental set-up used for this work is 
shown in Figure 1.15. In brief, the sample is flowed through a channel in a microfluidic device, 
which is 25 μm in height, 100 μm in width and 1 cm in length. The microfluidic devices used 
in this thesis were provided by Dr. Chris Taylor. The sample is then excited with a laser, 
corresponding to the wavelength of the fluorophore, which has previously been filtered and 
focused using a series of filters and mirrors to reject unwanted signals. The light emitted by the 
sample is then collected by two different APD detectors. This instrument was described in 
detail in references [121, 125]. 
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Figure 1.15. Schematic of the instrumental SM microscopy set-up. The sample is first 
diluted (1) and then injected into the microfluidic device (2). This device is fixed on a confocal 
microscope (3) and contains 100 μm wide channels in which radiation to excite A488 and A647 
(488 nm and 647 nm lasers, respectively) is focused. These laser beams (4) are combined and 
reflected by a series of dichroic mirrors (5) before illuminating the sample. The fluorescence 
from the fluorophores in the sample is then separated by another dichroic mirror (6), passed 
through a filter (7), and collected by two different detectors (8). The bursts of intensity are 
detected when labelled protein passes through the confocal volume (9). For FRET, the red laser 
(647 nm) is turned off and A647 is excited indirectly by the donor, A488. Figure modified from 
Horrocks and co-workers, 2015 [43]. 
 
1.5.5. Following HuL aggregation with extrinsic dyes 
 
The confocal set-up described above (Figure 1.15) can also be used to follow protein complexes 
using extrinsic dyes and label-free protein. This label-free method allows for the number of 
aggregates as well as their intensity to be tracked, providing insights into the mechanistic 
properties of fibril formation [134]. In this thesis, Thioflavin T (ThT) and pentameric formyl 
thiophene acetic acid (pFTAA) were used as the extrinsic dyes (Figure 1.16). The amyloid-
binding dye, ThT, is typically used as a probe to follow amyloid fibril formation as in the 
presence of fibrils it becomes highly fluorescent [135-137]. While pFTAA is also an amyloid-
binding dye, it has been shown to bind amyloid-β aggregates earlier than ThT making it a great 
alternative to detect pre-fibrillar species as well as fibrils [138, 139]. This method is also used 
in this thesis as a comparison to the experiments using labelled lysozyme in Chapters 3 and 4.  
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Figure 1.16. Structure of the extrinsic dyes, ThT and pFTAA. a) ThT. b) pFTAA. Structures 
drawn in ChemDraw Professional. 
 
1.5.6. Limitations of TCCD and SM FRET 
 
Although both TCCD and SM FRET offer a robust method for the study of protein complexes, 
samples need to be diluted to concentrations in the picomolar (pM) range. This requires the 
experimentalist to manually dilute each sample by 5-6 orders of magnitude, whilst using 
multiple eppendorf tubes and pipette tips, which can result in human error. In addition, this 
process of dilution is time-sensitive and could alter the population in the sample if the stability 
of some of the species is poor. The use of automated devices has been proved successful before 
[140], but their use in this thesis has not been possible due to the very specific conditions under 
which HuL undergoes fibril formation.  
 
1.6. Thesis aims 
 
Given the broad knowledge about the general mechanisms of the folding and unfolding of 
human lysozyme, it is of great interest to characterise its aggregation process at a molecular 
level in order to understand the intermolecular interactions involved in the early processes of 
fibril formation, as well as to gain insights into the structure of the species present during 
different stages of aggregation. In this thesis, the application of SM fluorescence will be used 
for the characterisation of the oligomeric populations present during fibril formation of HuL. 
In Chapter 2, the optimisation of the labelling of I59T HuL with A488 and A647, and the 
characterisation of the labelled-protein by different biophysical techniques will be presented. 
In Chapter 3, we will explore the use of a well-established SM microscopy approach [43] to 
study an enriched population of HuL oligomers before pursuing the characterisation of in situ 
formed HuL oligomers, produced using in vitro conditions that allow for the study of the effects 
of biomolecules (Chapter 4). Finally, the interactions between in situ HuL oligomers and the 
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extracellular chaperone, clusterin, will be explored using SM microscopy in Chapter 5. To the 
best of our knowledge, this thesis describes the first SM fluorescence study of the oligomeric 
population formed during fibril formation by a globular protein, and thereby allows for 
mechanistic details of amyloid formation and its regulation by a chaperone in a globular system 
to be compared to the aggregation pathways which have been characterised for IDPs related to 
misfolding diseases [42, 43, 90, 91].  
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: Fluorophore-labelling of human 
lysozyme 
 
2.1. Introduction 
 
In order to perform single-molecule fluorescence experiments with human lysozyme, a 
fluorophore needs to be introduced site-specifically to a single residue within the protein. In 
this chapter we explore the optimisation of this reaction as well as analyse the biophysical 
properties of the chemically-modified lysozyme and its feasibility for use in SM experiments.  
 
2.1.1. Chemical modification of human lysozyme in a site-specific manner 
 
Single fluorophores have been frequently incorporated into proteins by introducing single 
cysteine residues within a protein using site-directed mutagenesis [42, 118]. However, the eight 
cysteine residues within lysozyme are involved in the formation of four disulphide bridges, 
which are essential for the maintenance of the native-state structure and stability [141, 142], 
and hence they make it challenging to introduce a fluorophore at a specific cysteine residue. 
An alternative strategy involves targeting lysine residues, which has been shown to allow for 
selective labelling, using specific reaction conditions, due to the accessibility of individual 
lysine residues within a protein [143, 144]. Previous studies by Ahn and co-workers, 2012, 
showed that human lysozyme could be modified chemically in a site-specific manner at the 
lysine 33 residue (K33) [145]. This could be achieved due to the variability in the reactivities 
of the five lysine residues present in human lysozyme, with the K33 reactivity being kinetically 
favourable. This work also showed that the introduction of a biotin moiety into HuL at K33 
was advantageous as the probe molecule was solvent exposed in the fibrils and hence labelling 
at K33 could potentially be used to characterise the aggregation of lysozyme by different 
techniques such as NMR or SM fluorescence. The reaction of human lysozyme with the 
selected moiety was, in this case, achieved under certain conditions using an N-
hydroxysuccinimide (NHS) ester derivative of biotin. The same chemistry of conjugation 
applies for different NHS esters such as the fluorophores 5-carboxyfluorescein N-succinimidyl 
ester (F-NHS) and the N-succinimidyl ester derivatives of Alexa dyes, as well as nitroxide spin 
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labels used in NMR studies. The mechanism of the reaction consists of the side-chain amine 
group of lysine interacting with the carbonyl group of the NHS ester, resulting in the formation 
of an amide bond between the lysine side-chain and the fluorophore of interest (Figure 2.1). In 
this thesis, the method developed by Dr. Ahn and colleagues will be applied to the labelling of 
HuL with the two Alexa fluorophores already introduced in Chapter 1 (A488 and A647), which 
in turn will make it possible to apply fluorescence techniques to study the oligomeric species 
involved in HuL fibril formation and compare this process to previously reported oligomeric 
charaterisation of disease associated IDPs [29, 42-44]. Given that the fluorophores themselves 
differ in both molecular mass, with A488 being 643.4 Da and A647, 842. 02 Da, and overall 
charge i.e. A488 has two negative charges whereas A647 has three negative charges (Figure 
2.1), it is likely that the reaction conditions for each fluorophore may need to be optimised in 
order to achieve the introduction of single-labels into the protein.  
 
 
Figure 2.1. Labelling HuL with NHS-ester derivatives of Alexa fluorophores. The reaction 
between the lysine residue at position 33 (K33, highlighted in yellow) and the NHS-ester 
follows a SN2 mechanism where the bond between the NHS moiety and the Alexa fluorophore 
is broken simultaneously to the creation of an amide bond between the latter and the K33 side-
chain. The structure of HuL was produced using PyMOL (PyMOL Molecular Graphics 
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System, Version 1.7.4 Schrödinger, LLC), PDB entry 1JSF. The structures of A488 NHS-ester 
and A647 NHS-ester were drawn using ChemDraw Professional.  
 
2.1.2. Chapter aims 
 
This chapter will explore the labelling of I59T HuL with Alexa fluorophores in order to 
optimise the introduction of single-labels into the protein as it is required for SM experiments. 
Once this is confirmed, the biophysical properties of the labelled protein will be characterised 
to ensure that the introduced chemical moiety does not significantly alter the protein structure, 
native-state stability or the aggregation process. The labelled protein will then be used in the 
following chapters to further understand the mechanism of fibril formation in the lysozyme 
system using SM fluorescence.  
 
2.2. Results 
 
In order to use Alexa-labelled HuL for SM experiments, the labelling reaction needed to be 
optimised so that the formation of singly-labelled lysozyme was maximised. Singly-labelled 
implies that each protein molecule incorporates only one fluorophore. For the rest of this 
chapter, the non-natural variant I59T of human lysozyme will be used. As described in Chapter 
1, this variant has similar properties to the naturally occurring amyloidogenic variant I56T, and 
its extensive characterisation makes it an excellent tool to study lysozyme aggregation [67].  
  
2.2.1. Optimisation of the labelling of I59T HuL with Alexa fluorophores using 
different pH conditions and protein-to-dye ratios 
 
The method developed by Ahn and co-workers, described above, involved the reaction of 7 
μM WT HuL with an amine-reactive reagent containing a biotin moiety, N-(+)-biotinyl-6-
aminocaproic acid N-succinimidyl ester (BioNSE), using 1:100 or 1:500 protein-to-dye ratios 
in 0.1 M MES buffer (pH 5.0), with stirring for 20 h at room temperature [145].  Although very 
successful for the single-labelling of HuL with biotin, these conditions require large amounts 
of reagent, which is not ideal for the use of F-NHS and Alexa fluorophores, due to their high 
cost. For this reason, the reaction conditions were optimised first using F-NHS in order to 
minimise the amount of dye required to singly-label HuL. An increase in the reactivity between 
the dye and HuL was achieved by increasing the pH. The reaction of WT HuL with F-NHS 
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was optimised to yield the single-labelled protein by using a protein-to-dye ratio of 1:15 in 0.1 
M MES, pH 8.0 with stirring at 50 ˚C. In addition to similar spectroscopic properties to A488, 
F-NHS also contains negative charges at near-neutral pH. However, given that A488 has a 
slightly larger size, and A647 has a much larger size and is more negatively charged at near-
neutral pH, the reactivity of the dyes was expected to be different due to steric hindrance as 
well as at different pH; therefore, it was necessary to optimise the conditions, exploring a range 
of pH from 5-8 (see Table 6 for dye sizes). The reaction for A647 is optimal at pH 5.0, 45 ˚C 
as this dye was found to be too reactive using higher pH i.e. I59T HuL would quickly 
incorporate two dye molecules. This result suggests that the steric hindrance of this larger dye 
moiety is not significant enough to reduce the reactivity. On the other hand, pH 8.0, 45 ˚C is 
optimal for A488 as only one molecule is incorporated into the protein. The protein-to-dye 
ratio was also investigated over a range from 1:1 to 1:100, and the optimised ratio was found 
to be 1:1 and 1:1.5 for A647 and A488, respectively. The initial concentrations for the reaction 
were set to 70 µM for I59T HuL and 70 µM and 105 µM for A647 and A488, respectively. 
The temperature of the reaction was initially set at 50 ˚C, but the optimised temperature was 
found to be 45 ˚C. The yield of the reaction was found to be 5 ± 2 % for A647 and 10 ± 3 % 
for A488. After purification by chromatography using a strong cation exchange resin (monoS 
column) to separate the desired product from other species, mass spectrometry was used to 
confirm the level of labelling presented within the protein. A summary of the reaction 
conditions investigated can be found in Table 2. For the optimised conditions, I59T HuL was 
confirmed to be singly-labelled (Figure 2.2, a and b). Sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE) analysis of the reaction products shows fluorescently labelled 
I59T HuL for both dyes when the gel was imaged after excitation with either a 488 nm laser or 
a 633 nm laser (Figure 2.2, insets).  
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Table 2. Summary of reaction conditions for labelling human lysozyme with NHS ester 
fluorophores in 0.1 M MES (pH 8.0), 50 ˚C 
Sample Label Labelling reagent 
Protein-to-
dye ratio 
MW (Da) (labelling 
efficiency) 
F-WT HuL F-NHS 5-carboxyfluorescein 
N-succinimidyl ester 
1:15 15078.93 (single) 
F-I59T F-NHS 5-carboxyfluorescein 
N-succinimidyl ester 
1:15 15006.01 (single) 
A488-I59T A488 
Alexa-488 
N-succinimidyl ester 
1:5 15714.5 (double) 
A647-I59T A647 
Alexa-647 
N-succinimidyl ester 
1:15 
17207.9 (triple) 
18049.5 (quadruple) 
18891.4 (quintuple) 
A488-I59T* A488 
Alexa-488 
N-succinimidyl ester 
1:1.5 15196.84 (single) 
A647-I59T** A647 
Alexa-647 
N-succinimidyl ester 
1:1 15521.30 (single) 
*45 ˚C  
**pH 5.0, 45 ˚C 
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Figure 2.2. Labelling of I59T HuL with Alexa fluorophores. a) Mass spectrometry (MS) 
analysis of A488-I59T HuL (7 µM) after reaction in 0.1 M MES buffer (pH 8.0) with a 1:1.5 
lysozyme-to-A488 ratio. The peak at 15196.84 ± 0.49 Da corresponds to the single-labelled 
A488-I59T HuL. Inset: SDS-PAGE imaged by fluorescent emission of A488-I59T HuL. The 
band is located at around 14 kDa. b) MS analysis of A647-I59T HuL (7 µM) in 0.1 M MES, 
pH 5.0 with a 1:1 ratio, where the single-labelled peak appears at 15521.30 ± 0.46 Da. Inset: 
SDS-PAGE imaged by fluorescent emission of A647-I59T HuL. The band is located at around 
14 kDa. The excitation of the dyes was achieved with a blue laser (488 nm) for A488-I59T 
HuL and a red laser (633 nm) for A647-I59T HuL. Both reactions were done at 45 ˚C with 
constant stirring in darkness. Both samples were purified by strong cation exchange 
chromatography prior to mass spectrometry analysis.  
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2.2.2. Characterisation of the stability and structure of Alexa-labelled human lysozyme 
 
After successfully labelling I59T HuL with the Alexa fluorophores, the secondary structure 
and the thermostability of the labelled proteins were characterised by CD spectroscopy. CD 
spectroscopy measures the difference in absorbance between circularly polarised components 
and reports on the degree of chirality within a molecule, which can be used to observe the 
secondary and tertiary structures of proteins as well as to determine the midpoint temperature 
at which a protein unfolds [146]. Far-UV measures distinct spectra for the secondary structural 
elements such as α-helices, β-sheets and random coils. Near-UV CD monitors the tertiary 
structure, reporting on the conformation of aromatic residues found within the protein.  Far-
UV CD of the Alexa-labelled I59T HuL was monitored between 210-250 nm and compared to 
the I59T HuL monomer (Figure 2.3, a). Unfortunately, the presence of the Alexa dyes within 
the protein results in interference in the far-UV region, but it is possible to record the secondary 
structure of the labelled protein up to ~210 nm and from this analysis, it appears that the 
labelled protein is unaltered as compared to the unlabelled I59T HuL. In addition, thermal 
denaturation was monitored at 222 nm by CD spectroscopy. Calculating the temperature at the 
midpoint of the denaturation (where the protein is 50% unfolded) allows the comparison of 
native-state stability between the unlabelled and the labelled proteins. Thermal melts were 
fitted to a two-state model [74] and the denaturation midpoints (Tm) of A488-I59T HuL and 
A647-I59T HuL were calculated to be 71.3 ± 1.6 ˚C and 68.6 ± 1.6 ˚C, respectively. A 
comparison of these Tm values to those of the unlabelled I59T and WT HuL, as well as WT 
HuL labelled with F-NHS, can be found in Table 3. Although it appears, from the data, that the 
labelling with the Alexa dyes results in a destabilisation of the native-state thermostability of 
the I59T variant, it must be noted that the signal-to-noise ratio was quite low in the labelled 
protein samples, especially for A488-I59T and therefore it may have interfered with gaining 
accurate thermal denaturation curves (Figure 2.3, b-d). Due to the interference of the Alexa 
dyes in the CD measurements, a second technique was necessary to determine the unfolding 
transition. Differential scanning calorimetry (DSC) is a useful technique to identify transitions 
that induce a change in heat capacity and enthalpy and is useful for situations where samples 
are not well-resolved by spectroscopic techniques [74]. Unfortunately, the DSC was 
unavailable for further investigation of the Alexa-labelled I59T HuL native-state stability. It 
was possible, however, to measure the midpoint temperature for WT HuL and F-WT HuL, and 
both showed a single peak when the heat capacity was plotted against temperature (Figure 2.3, 
e). This result is characteristic of a two-state transition i.e. only one conformational transition 
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was detected by DSC. According to previous studies, this conformational transition 
corresponds to the cooperative conversion of the native-state into the intermediate state, leading 
to the hypothesis of two first-order transitions, which questions the three-state model as 
explained in detail in reference [74]. The Tm at the maximum heat capacity was found to be 
77.2 ± 0.3 ˚C for WT HuL and 73.5 ± 0.7 ˚C for F-WT HuL. This data confirms that the F- 
label, unlike previous work with biotin labelling, has a slight destabilising effect on the WT 
HuL protein. This result also shows that the Tm calculated from the denaturation followed by 
DSC is not significantly different from that obtained from the CD denaturation, even with the 
interference of the dye. Therefore, and due to the similarities between the fluorescein derivative 
and the Alexa dyes, it can be concluded that the temperatures at the midpoint of the 
denaturation calculated for the Alexa-labelled I59T HuL samples by CD denaturation are likely 
to be accurate enough for this characterisation. However, further analysis would be necessary 
for a more accurate characterisation, for example using tryptophan fluorescence. 
 
Table 3. Comparison of the denaturation midpoints (Tm) of WT and I59T HuL as 
measured by far-UV CD thermal denaturation and DSC. The Tm values correspond to an 
unfolded fraction of 0.5. The data are shown as the mean ± the standard deviation from three 
independent experiments. 
Sample Technique Tm (˚C) 
WT CD 79.9 ± 0.9 
WT DSC 77.3 ± 0.2 
F-WT CD 74.7 ± 0.9 
F-WT DSC 73.0 ± 0.1 
I59T CD 72.0 ± 0.4 
A488-I59T CD 71.3 ± 1.6 
A647-I59T CD 68.6 ± 1.6 
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Figure 2.3. Analysis of secondary structure and native-state stability of Alexa-labelled 
I59T HuL. a) Analysis of the secondary structure of I59T HuL (black), A488-I59T HuL (blue) 
and A647-I59T HuL (red) in terms of the Mean Residue Ellipticity (MRE) using far-UV CD 
spectroscopy. Both dyes interfere with the reading, making it impossible to record at 
wavelengths lower than 210 nm. The scans were recorded in triplicate, and the data shown is a 
representative data set. b) Thermal denaturation curve monitored in the far-UV region (222 
nm) for A647-I59T HuL (red). The midpoint temperature was calculated by fitting the observed 
ellipticities to a two-state model [74] to be 68.6 ± 1.6 ˚C. c), d) Thermal denaturation curve 
monitored in the far-UV region (222 nm) for A488-I59T HuL (blue) in terms of ellipticity (c) 
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and fraction unfolded (d). The interference of A488 is noticeable, and hence the fitted data is 
presented in terms of ellipticity (c), but the data could be fitted and the midpoint temperature 
was calculated to be 71.3 ± 1.6 ˚C. e) Evolution of heat capacity over increasing temperature 
for F-WT HuL (dark cyan) in water. The curve corresponds to a two-state transition and the 
midpoint temperature was calculated as the temperature at which the heat capacity was at its 
maximum, and was equal to 73.0 ± 0.1 ˚C. This result is comparable to that calculated from 
CD thermal denaturation, 74.7 ± 0.9 ˚C, which is shown in (f). The Tm from the CD thermal 
denaturation and DSC experiments (b-f) were calculated as the average from three independent 
experiments, and a representative data set of these experiments is shown.  
 
2.2.3. Spectroscopic characterisation of Alexa-labelled human lysozyme 
 
After probing their thermostability, the spectroscopic properties of the Alexa-labelled I59T 
HuL proteins were explored by different biophysical techniques (Figure 2.4 and 2.5). The 
absorbance spectra of 3.5 μM of A488-I59T and A647-I59T HuL were obtained between 200-
800 nm and compared to that of unlabelled I59T HuL (Figure 2.4). As expected, a single 
absorbance peak located in the region of 280 nm is observed in the spectrum for I59T HuL. 
This peak is typically due to the tryptophan amino acids in the protein [147, 148]. In 
comparison, both A488-I59T and A647-I59T HuL show two absorbance peaks: one between 
250-300 nm due to the presence of the protein and a second distinct peak with a maximum 
absorbance at approximately 490 nm and 651 nm which can be attributed respectively to the 
fluorophores A488 and A647 themselves (Figure 2.4). The excitation and emission spectra of 
labelled I59T HuL were also recorded (Figure 2.5). The excitation and emission maxima for 
A488-I59T HuL are 496 and 518 nm, respectively (Figure 2.5, a), and they are 657 and 672 
nm, respectively, for A647-I59T (Figure 2.5, b). The excitation spectra were collected by 
setting a constant emission wavelength of 517 and 672 nm (± 5 nm slit width), respectively for 
A488-I59T and A647-I59T HuL, and recorded between 250-650 nm for A488-I59T and 250-
700 nm for A647-I59T HuL. The emission spectra were collected by using an excitation 
wavelength of 494 and 651 nm (± 5 nm slit width), respectively, and emission was recorded 
between 500-650 nm for A488-I59T and 500-700 nm for A647-I59T HuL. The spectra for 
A488-I59T HuL were recorded at 600 V whilst those for A647-I59T HuL were collected at 
500 V as the maximum intensity for the recording was reached at 600 V, which explains the 
difference in intensity (Figure 2.5, a and b). The excitation and emission maxima shown by 
both dyes in the labelled protein correlate perfectly with those observed for the free dye 
(Section 1.4.3) and therefore these data suggest that the dyes do not suffer any significant 
perturbation to their spectroscopic properties when bound to the protein.   
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Figure 2.4. Spectroscopic characterisation of labelled I59T HuL (I). Comparison of the 
absorbance of I59T HuL (black), Alexa488-I59T HuL (blue) and A647-I59T HuL (red) in 
water. The spectra for all the samples show a peak at ~280 nm, which is typically indicative of 
the presence of protein. The spectra for A488-I59T and A647-I59T HuL also show an extra 
peak at approximately 490 and 651 nm, respectively. 
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Figure 2.5. Spectroscopic characterisation of labelled I59T HuL (II). a) Excitation (orange) 
and emission (blue) spectra of A488-I59T HuL in water with maxima at 496 and 518 nm, 
respectively. b) Excitation (green) and emission (purple) of A647-I59T HuL in water with 
maxima at 657 and 672 nm, respectively.  
 
2.2.4. Fibril formation 
 
In addition to characterising the native-state of the labelled proteins, their competence to form 
fibrils in the same manner as the unlabelled protein needed to be assessed. The conditions for 
fibril formation for destabilised variants of HuL were optimised by previous studies to be 0.1 
M citrate pH 5.0, 60 ˚C with stirring and have been fully characterised for the unlabelled I59T 
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variant before [67, 69, 145]. The aggregation of a stoichiometric mixture of A488-I59T and 
A647-I59T HuL (3.5 μM of each dye) under these conditions was followed by light scattering 
at 500 nm (Figure 2.6, a) and the resulting aggregates were imaged by transmission electron 
microscopy (TEM) (Figure 2.6, b). Light scattering was used to follow the aggregation as the 
typically used probe to follow aggregation kinetics, ThT (introduced in Section 1.5.5), could 
not be used as its fluorescence spectrum overlaps with that of the Alexa dyes. The 
stoichiometric mixture was chosen as these are the conditions required for the SM experiments. 
The results show that, within error, the aggregation rate of the labelled I59T HuL mixture is 
the same as the unlabelled protein. The midpoint for I59T HuL aggregation was found to be 
6.3 ± 1.1 h whereas that of labelled I59T HuL mixture was 5.7 ± 0.8 h. The midpoint was 
calculated as the time corresponding to a normalised light scattering signal of 0.5 i.e. the 
midpoint of the exponential increase. The fibrils of both unlabelled and Alexa-labelled I59T 
HuL show the same structural features when imaged by TEM (Figure 2.6, b and c).  
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Figure 2.6. Fibril formation of Alexa-labelled I59T HuL. a) In vitro aggregation monitored 
by light scattering at 500 nm for I59T HuL (black) and a stoichiometric mixture of A488-I59T 
and A647-I59T HuL (green) in 0.1 M citrate buffer, pH 5.0 with stirring at 60 ˚C. The data 
show the mean and the error bars represent the standard deviation in the midpoint of 
aggregation from three independent experiments. The normalised data was calculated using 
unity-based normalisation, where each point is calculated as (x-xmin)/(xmax-xmin) where x is the 
measured raw data, and xmin and xmax are the minimum and maximum values of the raw data, 
respectively. b), c) TEM images of the endpoint of aggregation for I59T HuL (b) and Alexa-
labelled I59T HuL (c), where the black scale bar represents 100 nm.  
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2.2.5.  Incorporation of Alexa dyes into HuL fibrils 
 
Previous research on the aggregation of α-synuclein showed a preference for A488-labelled 
monomer to be incorporated into the dually labelled fibrils [42]. Although this preference was 
only significant at the fibrillar level and did not affect the SM experiments used to follow the 
early stages of aggregation [42], the incorporation of the Alexa dyes into HuL fibrils was 
monitored in order to assess if a preference was also observed for this protein system. First, the 
concentration of labelled I59T HuL for each of the dyes needed to be measured accurately in 
order to ensure that a stoichiometric initial monomer concentration would be used. For this 
purpose, the concentration was checked by both amino acid analysis (AAA) at PNAC (Dept. 
of Biochemistry, University of Cambridge) and UV-vis spectroscopy. The results from AAA 
show no significant difference between this analysis and the data obtained by UV-vis 
spectroscopy and therefore the latter was used for concentration measurements of the labelled 
protein for the rest of this thesis due to ease and convenience of this methodology. Once the 
measurement of monomer concentration was proven to be reliable, the incorporation of the 
Alexa dyes was investigated using two different methods that assessed the concentration of 
monomeric A488-I59T and A647-I59T HuL at two different time points of the aggregation in 
which fibrils are already forming (9 and 24 h). The aggregation was set at a total initial 
monomer concentration of 7 μM (3.5 μM of each dye). The samples taken after 9 and 24 h 
were first centrifuged for 30 min at 11500 rcf to isolate the fibrils. The monomer concentration 
in the supernatant was then assessed by UV-vis absorbance and by fluorescence imaging of a 
SDS-PAGE analysis. This latter method involves the excitation of the sample with the 
appropriate laser and then imaging the fluorescence that is emitted by the fluorophore. After 9 
h, the concentrations of A488-I59T and A647-I59T HuL were measured in triplicate by 
absorbance at 494 and 651 nm, respectively, and were found to be 3.47 ± 0.08 μM and 2.38 ± 
0.06 μM, respectively. These data suggest that the labelled fibrils may have a preference for 
A647-I59T HuL monomers. The sample after 24 h showed a monomer concentration 
effectively equal to zero which suggests that all monomers had been incorporated in the fibrils 
by that time. The same supernatant samples were then analysed by SDS-PAGE and the 
resulting gel was imaged in the same manner as described in Section 2.2.1. The gel was first 
excited with a blue laser (488 nm), which illuminated A488-I59T HuL only, and then with a 
red laser (633 nm), exclusively illuminating A647-I59T HuL. The fluorescence emitted was, 
in both cases, lower for the mixture than for each of the dyes separately. No significant 
difference is observable between the fluorescence emitted by each of the fluorophores in the 9 
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h mixed time point when illuminated with the different lasers (Figure 2.7, a and b, lane 3). In 
order to investigate whether both dyes were incorporated into the fibrils and, additionally, 
whether they were able to produce FRET, the fibrils were imaged by Dr. Marie Bongiovanni 
using total internal reflection fluorescence microscopy (TIRFM). This method involves the 
observation of the fluorescence emitted in both the blue (A488) and red (A647) channels after 
the sample is excited with a particular laser, allowing the fibrils to be imaged [149]. The results 
show FRET and therefore it can be concluded that both dyes are indeed incorporated into the 
fibrils (Figure 2.7, c).  
 
 
Figure 2.7. Incorporation of Alexa dyes into HuL fibrils. a), b) SDS-PAGE imaged by 
fluorescence using a 488 nm (a) and a 633 nm laser (b). The lanes are labelled for Ladder (L), 
3.5 μM A488-I59T HuL (1), 3.5 μM A647-I59T HuL (2), 9 h (3) and 24 h time point (4). Both 
the 9 and 24 h time points were taken from an aggregation mixture of total initial monomer 
concentration equal to 7 μM (3.5 μM of each dye). In both cases, the mixture (lane 3) shows a 
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lower fluorescence than each of the dyes alone (lanes 1 and 2) which is consistent with 
monomer depletion by the formation of aggregates. No significant difference was observed for 
the fluorescence in lane 3 regardless of the laser used. c) TIRFM imaging of fibrils formed 
from equimolar concentrations of A488-I59T and A647-I59T HuL. When the sample was 
excited with a blue laser (488 nm), fluorescence was observed in both the A488 and the A647 
channels meaning there was FRET and hence both dyes were present in the fibrils. Image taken 
by Dr. Marie Bongiovanni.  
 
2.3. Conclusion and next steps 
 
Single-labelling of the I59T lysozyme variant, a model system for lysozyme amyloidosis, was 
successfully achieved with both A488 and A647. A488 was found to label I59T in a single 
manner when reacted at pH 8.0, 45 ˚C with a protein-to-dye ratio of 1:1.5. A647 was found to 
be more reactive than A488 and therefore a lower pH and a lower protein-to-dye ratio were 
needed (pH 5.0, 1:1 ratio) to achieve single-labelling of I59T HuL. After purification by strong 
cation exchange chromatography, the labelled proteins were characterised by different 
biophysical techniques to determine the effect of the dyes on the attributes of lysozyme. This 
analysis shows that the introduction of Alexa dyes to I59T HuL results in a slight decrease in 
the native-state stability, although no changes to the secondary structure are observed. The in 
vitro fibril formation of the Alexa-labelled I59T HuL is comparable to that of unlabelled I59T 
HuL, with the midpoint of aggregation being 5.7 ± 0.8 h and 6.3 ± 1.1 h, respectively, and the 
resulting fibrils show identical morphology. The investigation of the incorporation of the dyes 
into HuL fibrils, when present in an equimolar ratio, shows no significant preference for either 
of the dyes. This analysis also shows that FRET is observed in the fibrils, which confirms that 
both dyes are incorporated, and suggests that SM FRET should be a viable tool to follow the 
aggregation process. The facile nature of incorporating the Alexa-dyes into human lysozyme 
and its variants in a relatively controlled manner means that it is now possible to apply single-
molecule fluorescence experiments to the lysozyme system in order to gain insight into the 
early events of fibril formation for a globular protein. The next chapters in this thesis will 
involve carrying out these investigations. 
  
Chapter 3: Optimisation of a SM 
microscopy set-up to characterise HuL 
oligomers 
 
3. 1. Introduction 
 
SM microscopy is a powerful technique to study the oligomeric species present in protein 
aggregation. Previous studies have shown how this technique can be used effectively to 
monitor the oligomeric populations present during the aggregation of a diverse range of 
systems, including the SH3 domain of PI3 kinase, α-synuclein, the amyloid-β peptide and tau 
[44, 118, 130, 150, 151]. To date, most studies have focused on the aggregation processes of 
IDPs and therefore, in order to investigate the aggregation process of the globular human 
lysozyme, the SM microscopy set-up required some optimisation. In this chapter, we will test 
the set-up using lysozyme samples enriched with oligomers, following aggregation protocols 
reported for HEWL in the literature.  
 
3.1.1. Using oligomer-enriching conditions to optimise the SM microscopy set-up for 
HuL 
 
As mentioned in Chapter 1, the early species present along the aggregation pathway of human 
lysozyme have not been fully characterised as their low concentration and transient nature have 
made them challenging to detect [63]. Also, unlike other systems previously studied by TCCD 
and SM-FRET, introducing a single fluorophore label into HuL posed a challenge. However, 
recent developments in site-specific labelling of human lysozyme [145] as well as the 
development of label-free methods for detecting lowly populated species [75, 152], have 
opened up the possibilities to gain insight into the early aggregation events of this system.  
 
In order to optimise the SM microscopy set-up described in Section 1.5.4 to investigate HuL 
oligomers, we will use a positive control in which the oligomer formation is enriched. This 
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positive control relies on previous work on HEWL which showed that conditions containing 
high salt concentrations at acidic pH result in the formation of metastable oligomers [153, 154]. 
In those studies, the kinetic phase of HEWL was mapped as protein and salt concentrations 
varied (Figure 3.1). The results showed that as protein and/or salt concentrations increase, a 
critical concentration of oligomers is reached and this then nucleates the formation of, what 
seem like, curvilinear fibrils. This study involved monitoring aggregation with a range of 
HEWL concentrations from 6 μM to 1.4 mM, in the presence of 50 to 800 mM of NaCl [153].  
 
 
Figure 3.1. Metastable oligomer formation for HEWL. a) Kinetic phase of HEWL over 
different salt concentrations. Highlighted in purple is the region in which the formation of 
metastable oligomers and curvilinear fibrils is maximised. b) AFM imaging of the oligomers 
(top) and curvilinear fibrils (bottom). The scale bars represent 200 nm and 300 nm, 
respectively. Colour scale represents aggregate height in nm. Figure adapted with permission 
from references [153, 154].  
 
3.1.2. Chapter aims 
 
As little is known about the population and stability of any oligomer species that are formed in 
situ under our standard HuL fibril forming conditions (pH 5.0, 60 ˚C), the SM microscopy set-
up introduced in Section 1.5.4 will be optimised using samples enriched with oligomeric 
species of HuL (400 mM, pH 2.0 [153]) . In this chapter, we will first optimise the oligomer-
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enriching conditions on HuL (as the previous report used HEWL). Next, the detection of 
oligomeric species using SM fluorescence microscopy will be evaluated first using Alexa-
labelled human lysozyme and then using label-free methods.  
 
3.2. Results 
 
The biophysical characterisation of WT HuL, and unlabelled and Alexa-labelled I59T HuL in 
the oligomer-enriching conditions was first investigated to ensure no significant alterations in 
their properties were observed before using these as a positive control for the SM techniques. 
Once the effect of these conditions on our system were established, their use for the 
optimisation of the SM microscopy set-up was pursued.  
 
3.2.1. Spectroscopic characterisation of singly-labelled I59T HuL under oligomer-
enriching conditions 
 
Although the Alexa fluorophores are pH insensitive over a broad range of pH [155], their 
spectroscopic properties under oligomer-enriching conditions (pH 2.0, 400 mM NaCl) were 
investigated by measuring their absorbance.  The absorption spectra of A488-I59T and A647-
I59T HuL were obtained between 200-600 nm and compared in 400 mM NaCl at pH 2.0, 5.0 
and 7.0 conditions. The concentration of NaCl was chosen to maximise oligomer formation 
whilst minimising the amount of protein needed, as well as avoiding the formation of 
amorphous aggregates (Section 3.1.1). As expected, the A488 and the A647 labelled protein 
spectra contain an absorbance peak in the region between 250-300 nm and a distinct maximum 
absorbance at around 490 nm and 650 nm, respectively, which can be attributed to the 
fluorophore (Figure 3.2). No absorbance shifts or significant changes in overall intensity are 
observed for the spectra recorded under these conditions (Figure 3.2). Even though chloride 
ions are known for being good quenchers and their effect in data collection by SM fluorescence 
techniques has been proved before [43], in this chapter the samples were dissolved in water 
before being injected into the SM set-up, which minimises the potential effect of said ions. It 
can therefore be concluded that these conditions (pH 2.0, 400mM NaCl) can be used without 
disturbing the signal of the Alexa dyes.   
Optimisation of a SM microscopy set-up to characterise HuL oligomers 
 
56 
 
 
Figure 3.2. Spectroscopic comparison of Alexa-labelled I59T HuL under different pH 
conditions and with 400 mM NaCl. UV-vis spectra of A488-I59T HuL (a) and A647-I59T 
HuL (b) at pH 2.0 (red), 5.0 (green) and 7.0 (blue). Typically, a peak at ~280 nm is indicative 
of the presence of protein and the spectra show two extra peaks at approximately 490 nm (a) 
and 650 nm (b) due to the presence of the dye. No significant difference is observed for the 
different pH conditions. 
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3.2.2. Native-state stability and structure of unlabelled and Alexa-labelled HuL under 
oligomer-enriching conditions 
 
Once the Alexa dyes were proven to be functional, the native-state stability of HuL was 
investigated in the 400 mM NaCl, pH 2.0 conditions. The secondary structure and 
thermostability of WT and I59T HuL were characterised by CD spectroscopy. Far-UV was 
monitored between 200-250 nm and compared to the data collected using the pH 5.0 
conditions. The results for both WT and I59T HuL show a slight difference in the secondary 
structure, focused on the 210 nm region at pH 2.0 and pH 5.0 (Figure 3.3), which may be 
explained by the highly charged environment at pH 2.0, 400 mM NaCl conditions. Far-UV 
thermal denaturation was performed by monitoring the change at 222 nm with increasing 
temperature. As described in Section 2.2.2, the thermal melts were fitted to a two-state model 
[74] and the Tm of WT and I59T HuL in the pH 2.0 conditions were calculated to be 65.4 ± 1.8 
˚C and 58.7 ± 2.6 ˚C, respectively (Table 4). The Tm of WT and I59T HuL in the pH 5.0 
conditions were calculated to be 79.9 ± 0.9 ˚C and 72.0 ± 0.4 ˚C, respectively [75]. Therefore, 
the thermal denaturation at pH 2.0 shows an average destabilisation of 13.3 ˚C for I59T HuL 
and of 14.5 ˚C for WT HuL (Figure 3.3 and Table 4). These results are in agreement with the 
difference in stability previously reported for the midpoint temperatures of HuL at pH 5.0 and 
pH 1.2 [74, 75, 156]. 
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Figure 3.3. Analysis of native-state structure and thermostability of WT and I59T HuL 
monitored by CD spectroscopy in the far-UV region. a), b) Comparison of the secondary 
structure of WT HuL (a) and I59T HuL (b) in the pH 2.0, 400 mM NaCl conditions (red) and 
in the 0.1 M citrate, pH 5.0 conditions (green). c), d), e), f) Thermal denaturation of WT HuL 
(c, e) and I59T HuL (d, f) in the far-UV region (222 nm) using the pH 2.0 (c, d) and the pH 5.0 
conditions (e, f). The unfolded fraction was calculated as described in reference [145]. In (a) 
and (b), the data show the mean and the error bars represent the standard deviation from three 
independent experiments.  
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Table 4. Comparison of the midpoint temperatures (Tm) of WT and I59T HuL as 
measured by far-UV CD thermal denaturation. The Tm values correspond to an unfolded 
fraction of 0.5. The data are shown as the mean ± the standard deviation from three independent 
experiments. 
 Conditions (pH) Tm (˚C) 
WT 5.0 79.9 ± 0.9 
WT 2.0 65.4 ± 1.8 
I59T 5.0 72.0 ± 0.4 
I59T 2.0 58.7 ± 2.6 
 
 
3.2.3. Optimising HuL concentration in order to maximise oligomer formation 
 
After the native-state stability of both WT and I59T HuL was explored, the aggregation kinetics 
using different concentrations of WT HuL in 400 mM NaCl, pH 2.0 were followed by 
measuring ThT fluorescence over time in order to maximise the formation of oligomeric 
species. Since the purpose of these experiments was simply to be able to produce oligomer-
enriched samples to inject into the SM set-up, the more stable WT protein was used, as it is 
more readily available and therefore allowed us to sample a variety of concentrations for this 
optimisation stage. Once the conditions were established for the WT protein, the Alexa-labelled 
I59T variant was used for further analysis by TCCD and SM FRET (Section 3.2.7).  
 
To better observe the enrichment of oligomeric species, the kinetic traces were plotted as log 
ThT intensity as described by Hasecke and co-workers [34]. The results show a lag phase 
observable at 70 μM WT HuL, which then disappears into an exponential curve for higher 
concentrations of WT HuL (Figure 3.4). This early exponential region then reaches a short 
plateau before increasing again and reaching a second plateau, most clearly observable at 420 
μM (Figure 3.4, d). The first exponential corresponds to the formation of metastable oligomers 
that lead to curvilinear fibrils, whereas the formation of rigid fibrils corresponds to the second 
exponential [153, 154]. In order to maximise the amount of oligomers and minimise the amount 
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of protein needed for further experiments, the rest of this chapter will focus on protein 
concentrations between 210 and 350 μM HuL, as stated in the corresponding sections.  
 
 
Figure 3.4. Kinetic characterisation of different concentrations of WT HuL in 400 mM 
NaCl, pH 2.0 conditions. A flat lag phase is observed for 70 μM WT HuL (a). Progressive 
steepening is observable at 210 (b), 280 (c), and 420 μM (d). The logarithm of the ThT intensity 
is shown in order to highlight the first exponential as described in reference [153]. The data 
show the mean and the error bars represent the standard deviation from three independent 
experiments.  
 
3.2.4. Characterisation of fibril formation using oligomer-enriching conditions  
 
After choosing the HuL concentration necessary for maximising oligomer formation, the 
morphology and stability of the fibrils formed using 400 mM NaCl, pH 2.0 were investigated 
and compared to those of fibrils formed using pH 5.0 conditions. The aggregation of WT HuL 
(350 μM) was set at 52 ˚ C in 400 mM NaCl, pH 2.0 and monitored by ThT fluorescence (Figure 
3.5, a). The conformational stability of WT HuL fibrils formed under these conditions was 
established by depolymerisation using guanidine thiocyanate (GdnSCN) (Figure 3.5, b), giving 
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a midpoint of depolymerisation of 3.19 ± 0.07 M (data courtesy of Kimberley Callaghan). This 
result is in accordance with the midpoint of denaturation of 2-3 M GdnSCN reported in 
reference [156] for HuL fibrils formed under acidic conditions without salt. The resulting fibrils 
after 70 h were imaged by transmission electron microscopy (TEM), which shows linear fibrils 
that are distinctively longer than those formed by HuL using pH 5.0 conditions, and similar in 
size and structure to those formed without salt at pH 2.0 [156] (Figure 3.5, c). The fibrillar 
morphology and size are equivalent to those shown previously for the HEWL oligomer-
enriching conditions [153, 154]. Finally, the ThT fluorescence of the aggregates at the end-
point of the aggregation reaction was measured in triplicate. The samples from the pH 2.0 
conditions were taken after 17 h, which corresponds to the end of the first plateau (Figure 3.5, 
a), where previous studies have shown the presence of oligomers and curvilinear fibrils under 
these conditions [153, 154]. This time point was chosen because it corresponds to the end of 
the time period that will be studied by SM microscopy later in the chapter. For the pH 5.0 
conditions, the time points were taken after 24 h, when all the monomer has been incorporated 
into fibrils (as measured by absorbance at 280 nm and SDS-PAGE analysis). The fibrils formed 
under the pH 5.0 conditions show a higher ThT fluorescence than the aggregates formed under 
the pH 2.0 conditions after 17 h (Figure 3.5 d). This result may be explained by the presence 
of a higher β-sheet content in the case of the fibrils formed at pH 5.0, as compared to that of 
those present after 17 h in the pH 2.0 conditions. This result may also be explained by the 
presence of oligomers and curvilinear fibrils at this time point in the pH 2.0 conditions as 
reported in references [153, 154]. 
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Figure 3.5. Characterisation of fibrils formed using 400 mM NaCl, pH 2.0 conditions. a) 
Kinetic characterisation as followed by ThT fluorescence for 350 μM WT HuL. b) Stability of 
fibrils formed at pH 2.0 as measured by GdnSCN depolymerisation. Graph courtesy of 
Kimberley Callaghan. c) TEM image of fibrils formed after 70 h in 400 mM NaCl (pH 2.0). 
Inset: HuL fibrils formed using pH 5.0 conditions. The fibrils formed using pH 5.0 conditions 
are shorter than those formed using pH 2.0 conditions. The scale bars represent 100 nm. d) 
Comparison of the ThT fluorescence shown by the aggregates formed after 17 h in pH 2.0 
conditions (red) and by the mature amyloid fibrils formed after 24 h in pH 5.0 conditions (blue). 
The fibrils formed at pH 5.0 show a slightly higher ThT fluorescence than those formed at pH 
2.0. This result may be explained by the presence of oligomers and curvilinear fibrils at this 
time point in the pH 2.0 conditions [153, 154]. For (a) and (d), the data show the mean and the 
error bars represent the standard deviation from three independent experiments.  
 
3.2.5. Characterisation of HuL oligomers formed in acidic conditions using conventional 
biophysical techniques 
 
Once the native-state and the fibrillar state of HuL using oligomer-enriching conditions had 
been characterised by different biophysical techniques, the oligomeric species were 
characterised in bulk by atomic force microscopy (AFM) and dynamic light scattering (DLS). 
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DLS can be used to determine the size of molecules in solution by measuring their light 
scattering [157]. Although it is not very accurate for heterogeneous mixtures, as it is biased 
towards big molecules, it has been used here to observe whether any species, other than the 
monomer, was formed in the initial period of aggregation. Indeed, at 0 h only one peak was 
observed and it was centred at 1-2 nm, which is consistent with the size of a monomer (Figure 
3.6, a). After 0.5 h, two peaks were observed, one was still consistent with the monomer (1-2 
nm) whilst the second one was shifted to the right corresponding to a size of 3-4 nm (Figure 
3.6, b). This second peak was even more distinct after 1.5 h, when the peak was clearly 
separated from the monomer with a size of 4 nm (Figure 3.6, c). Finally, another DLS 
measurement was taken after 7.5 h where only the peak centred at 4 nm was observed after 
centrifugation to remove the large aggregates (Figure 3.6, d). Before centrifugation, large 
aggregates could be observed in the region of 1-1.5 μm (Figure 3.6, c, inlet). These large 
aggregates were observed from 2.5 h, which is in accordance with previous results where 
curvilinear fibrils were formed after 2 h [153, 154]. The size of the oligomeric peak 
(approximately 4 nm in diameter) is also consistent with reference [154]. In addition, AFM 
images of the aggregates formed after 7.5 h show spherical oligomers of approximately 50-100 
nm in diameter (Figure 3.6 d, inlet) which is consistent with what was previously published 
[153, 154]. 
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Figure 3.6. Characterisation of HuL oligomers formed in acidic conditions using 
conventional techniques. DLS measurements of WT HuL after 0 (a), 0.5 (b), 1.5 (c) and 7.5 
h (d). a) At 0 h, one peak is observed at 1-2 nm. b) After 0.5 h, two peaks can be observed, one 
still centred at 1-2 nm and a second peak at 3-4 nm. c) After 1.5 h, the two peaks centred at 1-
2 nm and 4 nm are clearly distinct. Inset: DLS shows large aggregates of around 1 μm in 
diameter before centrifugation after 2.5 h. d) After 7.5 h, only the peak at 3-4 nm is observed 
after centrifugation. Inset: AFM image of oligomers formed after 7.5 h. The scale bar represents 
500 nm and the colour scale represents heights with 0-2.5 nm in brown and 3-10 nm in white. 
AFM image provided by Ryan Limbocker.  
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3.2.6. Characterisation of HuL oligomers formed in acidic conditions using Alexa-
labelled I59T HuL  
 
After successfully detecting the presence of unlabelled oligomeric species using DLS and 
AFM, we next investigated whether we could monitor Alexa-labelled HuL fibril formation 
with the SM microscopy set-up, described in Section 1.5.4, to achieve three goals; 1) detect 
oligomeric species at picomolar concentrations, 2) obtain oligomeric distributions using TCCD 
and 3) use SM FRET to gain structural insight into the oligomeric species present in the early 
stages of aggregation. As discussed in Section 1.5.3, SM FRET requires the dyes to be in close 
enough proximity within the aggregates to transfer energy whereas TCCD only requires the 
two fluorophores to be present together within the same aggregate. Therefore, using TCCD 
initially seemed to be the best approach; however, TCCD proved to be very challenging due to 
issues with Alexa-labelled HuL sticking to the microfluidic device and the gel loading tips used 
to inject the sample into the microfluidic device, resulting in perturbation of the SM signal. In 
order to prevent the sticking, the gel tips were coated with 1 mg/ml of bovine serum albumin 
(BSA). This procedure greatly reduced any disturbance of the signal.  
 
The Alexa-labelled I59T HuL was aggregated under the conditions described in Section 3.2.4 
and different time points were taken and diluted to 25 pM before being injected into the 
microfluidic device at a flow rate of 0.61 cm s-1. The samples were maintained on ice (which 
prevents dissociation of the oligomers) until diluted. Analysis of the data from each time point 
was performed as described in Section 1.5.2. The results show that the number of oligomers 
increases with time for the first 2 h and then decrease after 7 h (Figure 3.7, a). This decrease 
may be related to the oligomeric species converting into fibrils. The oligomers detected can be 
further segmented into apparent size categories. Here, the size has been divided into three 
categories: very small oligomers (dimers to tetramers), medium oligomers (5-15 monomers) 
and large oligomers (16-50 monomers). Even though the total number of small oligomers does 
increase over time, the fraction of these small species decreases with time whilst that of medium 
and large oligomers increase over time (Figure 3.7, b). From these observations, it appears that 
the formation of small oligomers is happening at a slower rate than the formation of the larger 
oligomers. This suggests that the conversion from smaller to larger species may occur at a 
faster rate than the small species formation and hence the ratio of large-to-small species 
increases over time. In addition, the percentage of coincident bursts (here expressed as the 
percentage of oligomeric species) also increases with time, reaching 10% after 7 h (Figure 3.7, 
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c). Finally, the average size of the sample for each time point was calculated, resulting in 
approximately eight monomers per aggregate. Although the average size is only approximate, 
as explained in Section 1.5.3, this result is in accordance to the size estimated previously by 
AFM under these conditions [153, 154].  
 
 
Figure 3.7. TCCD characterisation of Alexa-labelled I59T HuL oligomers formed in 
acidic conditions. a) The numbers of oligomers detected by TCCD for each time point were 
classified by approximate size: 0 (black bar), 1 (orange), 2 (green) and 7 h (blue). The number 
of events detected for small species (apparent size of 2-4 monomers) increases between 0 and 
2 h and decreases at 7 h, likely due to their conversion into curvilinear fibrils. b) Fraction of 
events categorised by approximate size for the different time points (0, 1, 2, 7 h in black, 
orange, green and blue, respectively). The proportion of small oligomers decreases over time 
whilst that of the medium oligomers (apparent size of 5-15 monomers) increases with time. 
The fraction of large oligomers (apparent size of 16-50 monomers) also increases in the first 2 
h and then remains relatively constant after 7 h. c) Percentage of oligomeric species over time. 
The percentage of oligomers reaches 0.8% after 1 h, 5.0% after 2 h, and 9.7% after 7 h. d) 
Average apparent size over time in approximate number of monomers. The oligomeric species 
show an average size of about 8 monomers, which is in accordance to previous studies [153, 
154].  
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With the encouraging results from the initial TCCD experiments, we next investigated whether 
we could apply SM FRET to our system. Previously, SM FRET has been used to highlight 
structural differences within oligomeric populations and this can give insights into transitions 
which may be present during the aggregation pathway [42, 43]. The same protocol as for TCCD 
was followed with the exception that the red laser was now turned off. The results show an 
increase in the size and the FRET efficiency after 1-2 h into the aggregation process (Figure 
3.8). An increase in the FRET efficiency corresponds to a more efficient energy transfer 
between the Alexa fluorophores, which suggests a more structured and tightly packed oligomer 
structure. This result shows that SM FRET can be used to study the early stages of the 
aggregation pathway for the HuL system and gain insight into the structural and mechanistic 
details that govern it.  
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Figure 3.8. SM FRET characterisation of Alexa-labelled I59T HuL oligomers formed in 
acidic conditions. 2D plots of FRET efficiencies against the apparent oligomeric size in 
number of monomers for 0 (a), 1 (b) and 2 h (c). The FRET efficiency is proportional to the 
rigidity of the aggregate structure, with a higher FRET efficiency being indicative of a more 
structured species. The colour scale represents the amount of species detected in a logarithmic 
scale. After 1 and 2 h, both size and FRET efficiency increase.  
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3.2.7. SM fluorescence characterisation of HuL oligomers using extrinsic dyes  
 
Although a fantastic tool to monitor the oligomer populations present during fibril formation 
of a protein, and to gain insight about the mechanism of fibril formation, using labelled samples 
has limitations as the presence of the fluorophores may alter the kinetics of the aggregation and 
the structural properties of the oligomeric species [158, 159]. For this reason, recent studies 
have developed methods to detect label-free aggregates in vitro and in vivo, opening up a range 
of new applications, including as diagnosis tools for the early detection of aggregates in human 
biological fluids [134, 152]. In this section, we will explore the use of label-free SM 
microscopy for the detection of WT HuL oligomers, formed under the conditions described in 
Section 3.2.4, using pFTAA and ThT as extrinsic dyes (for more information on these dyes, 
see Section 1.5.5). During the early stages of aggregation, different time points were taken and 
diluted to 10 μM, where the dilution was considered as a function of initial monomer 
concentration. The dye, either pFTAA or ThT, was then added to each time point for a final 
concentration of 30 nM and 5 μM, respectively. The samples were injected into the microfluidic 
device to monitor the appearance of pFTAA or ThT fluorescence, which corresponds to their 
binding to aggregates. The number of fluorescent bursts and their intensities were measured 
over time. The fluorescent signal from ThT and pFTAA can be used to reveal structural 
information about the aggregates as the fluorescence intensity is proportional to oligomer size 
and β-sheet content. In addition, the number of bursts or events can provide insights into the 
mechanistic details of the aggregation [134]. When ThT is used as the extrinsic dye, the number 
of events is effectively zero at 0 h, which is expected as monomers are not ThT-active (Figure 
3.9, a). The number of events increases after 0.5 h and then remains relatively constant until 
the 6 h time point. The total intensity also increases within the first 0.5 h and continues to do 
so until 6 h (Figure 3.9, b), in a similar way to the increase in ThT signal observed using 
conventional ThT fluorescence measurements in a plate reader over the same time-course 
(Figure 3.5, a). The average intensity increases rapidly until 3 h, after which it remains 
relatively constant until 6 h (Figure 3.9, c). The average intensity for each time point was 
calculated as the total intensity divided by the number of events and it correlates to the average 
size and β-sheet content present in the sample at any particular time point.  This result suggests 
that either the size and/or the β-sheet content present in the sample increase over time until 3 
h, after which they remain constant. Further analysis using fluorophore-labelled protein and 
monitoring the ratio of pFTAA or ThT intensity to that of the fluorophore over time would be 
needed to assess whether both size and β-sheet content increase, as the intensity of the 
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fluorophore is proportional to size and not to β-sheet content. Finally, the data from this 
experiment also allows the classification of the aggregates observed at each time point 
according to their intensity, to determine how the proportion of low to high intensity oligomers 
changes with time. The number of intensity segments was established at 5 and the intensity 
ranges were distributed evenly so the same number of intensities was considered for each 
intensity range. The selection of the intensity ranges was made by dividing the difference 
between the maximum and the minimum intensities by 5, and then including the same number 
of intensities in each intensity range. The number 5 was chosen to minimise the number of 
intensity ranges whilst still allowing for the detection of any changes in the distribution of the 
intensity measured over time. The fraction of events corresponding to the lowest intensity range 
decreases whilst the proportion of higher intensity species increases over time (Figure 3.9, d). 
This result shows that over time there is a higher proportion of high intensity aggregates and 
hence the population distribution shifts towards larger sizes and/or higher β-sheet content over 
time. In fact, whereas around 50% of the events after 0.5 h correspond to higher intensity 
species, these account for 60% after 6 h (Figure 3.9, d).  
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Figure 3.9. SM characterisation of WT HuL oligomers formed under acidic conditions 
using ThT as the extrinsic dye. a) Number of events over time. For time 0 h, effectively no 
events are observed. After 0.5 h, the number of events increases and then plateaus until 6 h. b) 
Change in total intensity over time. The total intensity increases steeply from 0 to 3 h, when it 
starts increasing at a slower rate. This corresponds well to the ThT signal observed in bulk 
(Figure 3.5, a). c) Normalised average intensity over time. The average intensity was calculated 
as the total intensity divided by the number of events for each time point. The average intensity 
increases over time until approximately 3 h, after which it remains relatively constant. The 
normalised data was calculated using unity-based normalisation, where each point is calculated 
as (x-xmin)/(xmax-xmin) where x is the measured raw data, and xmin and xmax are the minimum 
and maximum values of the raw data, respectively. d) Change in the fraction of events 
corresponding to different intensity ranges over time. The fraction of species that fluoresce at 
the lower intensity range (140-200 photon counts, in blue) decreases over time whilst that of 
higher intensity species (200-260, in red; 260-320, in orange; 320-380, in yellow; and 380-440 
photon counts, in green) increases over time. The graphs show the mean and the error bars 
represent the standard deviation from three independent experiments performed on different 
days.  
 
The data obtained when pFTAA is used as the extrinsic dye shows that the number of events 
increases after 0.5 h and then remains constant until approximately 6 h, when it increases again 
until the 9 h time point (Figure 3.10, a). The total intensity for each time point follows a similar 
trend to the number of events (Figure 3.10, b) and is also similar to the ThT signal in bulk 
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(Figure 3.5, a). The average intensity was then calculated as described above and the results 
show a steep increase after 0.5 h, after which it remains constant until 6 h when it decreases 
until 9 h (Figure 3.10, c). The fluctuations in the data may be explained by the heterogeneity 
of the mixture, especially after 4-6 h when the oligomers and curvilinear fibrils undergo the 
mechanistic changes to evolve into rigid fibrils [153, 154]. Finally, the aggregates observed by 
pFTAA fluorescence were segmented according to their intensity (Figure 3.10, d). As described 
before for ThT, the intensities were segmented evenly into 5 ranges and then the fraction of 
events corresponding to each range was calculated and plotted against time (Figure 3.10, d). 
The fraction of high intensity oligomers increases within 0.5 h and then the distribution of the 
population remains constant until 9 h. These data suggest that oligomers are formed within 0.5 
h, after which the population distribution appears to be constant until the 9 h time point.   
 
 
Figure 3.10. SM characterisation of WT HuL oligomers formed under acidic conditions 
using pFTAA as the extrinsic dye. a) Number of events over time. The number of events 
increases after 0 h, remains relatively constant from 0.5 to 6 h and then appears to increase 
between 6 and 9 h. b) Change in total intensity over time. The total intensity increases steeply 
between 0 and 0.5 h, when it starts increasing at a slower rate until 9 h. c) Normalised average 
intensity over time. The average intensity increases steeply 0-0.5 h and then remains constant 
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until 6 h, after which it appears to decrease. The normalised data was calculated using unity-
based normalisation, where each point is calculated as (x-xmin)/(xmax-xmin) where x is the 
measured raw data, and xmin and xmax are the minimum and maximum values of the raw data, 
respectively. d) Change in the fraction of events corresponding to different intensity ranges 
over time. The fraction of species that fluoresce in the lower intensity range (50-110 photon 
counts, in blue) decreases whilst that of the higher intensity species increases within 0.5 h (110-
170, in red; 170-230, in orange; 230-290, in yellow; and 290-350 photon counts, in green). The 
graphs show the mean and the error bars represent the standard deviation from three 
independent experiments performed on different days.  
 
The results shown using ThT and pFTAA as extrinsic dyes in this section can be compared to 
the fluorescent signal shown in bulk (Figure 3.11). This comparison shows that using SM 
microscopy with ThT allows for a slightly earlier detection of species than using the 
conventional method in a plate reader (Figure 3.11, a). For pFTAA, no significant changes in 
the fluorescence can be observed using the plate reader whereas SM microscopy shows an 
increase in total intensity after 0.5 h (Figure 3.11, b). The plate reader data shown in Figure 
3.11 (b) represents the mean of a set of 5 samples ran simultaneously; however, more 
repetitions are needed to further determine whether pFTAA fluorescence is detectable using 
the pH 2.0 conditions in the plate reader.  
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Figure 3.11. Comparison of ThT and pFTAA fluorescent signals as monitored by SM 
microscopy and in bulk measurements. a) Normalised ThT intensity as detected by SM 
microscopy (orange) and by conventional ThT fluorescence measured in a plate reader (black). 
The high ThT intensity detected at 0 h is normal for measurements in the plate reader as the 
signal equilibrates, and is frequently shown in the literature [35]. The normalised data was 
calculated using unity-based normalisation, where each point is calculated as (x-xmin)/(xmax-
xmin) where x is the measured raw data, and xmin and xmax are the minimum and maximum 
values of the raw data, respectively. b) pFTAA total intensity as detected by SM microscopy 
(orange) and in the plate reader (black). In the plate reader, no significant change in the pFTAA 
fluorescence is observed whereas SM detects species after 0.5 h. The raw data is shown for 
clarity. The data shown from SM is the mean and the error bars represent the standard deviation 
from three independent repeats. The data from the plate reader measurements is the average 
and the error bars represent the standard deviation from five samples run simultaneously.  
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The results obtained using ThT and pFTAA are not directly comparable, as it appears that each 
dye binds different species along the aggregation pathway. This is consistent with previous 
studies where pFTAA was shown to be less specific for β-sheet structure and able to bind to 
earlier species in the aggregation pathway [138, 139]. Although this may or may not be the 
case here, it is clear that both dyes indicate that there are oligomeric species present early in 
the aggregation pathway under these conditions. Therefore, it is clear that we can detect label-
free human lysozyme oligomers at μM concentrations using the SM microscopy set-up, and 
with these positive results, we then looked to analyse the in situ fibril formation of the I59T 
variant.   
 
3.3. Conclusion and next steps 
 
In this chapter, the use of the SM microscopy set-up described in Section 1.5.4 was explored 
to detect HuL oligomers formed under oligomer-enriching conditions. While the Alexa dyes 
show no disturbance in their properties under these conditions (400 mM NaCl, pH 2.0), the 
native-state stabilities of WT and I59T HuL show an average destabilisation of 13.3 ˚C for 
I59T HuL and of 14.5 ˚C for WT HuL as detected by CD spectroscopy, which is comparable 
to other studies using acidic conditions to induce lysozyme fibril formation [74, 75, 156, 160]. 
A slight change in the secondary structure in the 210 nm region is also detected. The 
morphology of the fibrils formed under these conditions was studied by TEM, which shows 
that these are longer than those formed under pH 5.0 conditions. Next, the detection of the 
oligomeric species was achieved by DLS and AFM. With the presence of oligomers confirmed, 
we moved on to perform TCCD analysis using Alexa-labelled I59T HuL samples and working 
in the picomolar concentration range. Although TCCD proved challenging, oligomers were 
successfully detected at 25 pM after 1-7 h of aggregation. The apparent size of these oligomers 
increases over time and the average size was calculated to be approximately 8 monomers, 
which is in agreement with previous work under these conditions [153, 154]. Finally, the 
feasibility of SM FRET was explored and the results show an increase in size and FRET 
efficiency after 1-2 h. Next, we explored the use of label-free SM microscopy methods using 
two extrinsic dyes, ThT and pFTAA, to determine whether unlabelled HuL oligomers could be 
detected using the SM microscope after dilution to μM concentrations, and also to confirm the 
presence of oligomers, as detected by TCCD and SM FRET. Both ThT and pFTAA show the 
formation of oligomeric species after 0.5 h and the size and/or the β-sheet content of these 
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species appear to increase over time. With the SM microscopy set-up optimised to follow HuL 
oligomeric species, we wished to focus our attention towards our favoured fibril forming 
conditions (pH 5.0, 60 ˚C), as the stable oligomers used in this chapter have a complex 
aggregation pathway and are not physiologically relevant (due to high protein concentrations, 
low pH and high salt concentration). As our group has used pH 5.0, 60 ˚C to extensively study 
biomolecules which inhibit lysozyme fibril formation, understanding the aggregation under 
these conditions would provide us with vital mechanistic information. The characterisation of 
HuL oligomers formed under our favoured conditions will be investigated in Chapters 4 and 5. 
Chapter 4: Characterisation of in situ 
formed HuL oligomers using SM 
fluorescence microscopy 
 
4.1. Introduction 
 
In Chapter 3 we determined the feasibility of using the SM microscopy set-up to detect HuL 
oligomers at both micromolar and picomolar concentrations using an oligomer-enriched 
sample. In this chapter, we will use this set-up to investigate the structural nature of in situ 
oligomeric species formed under more physiologically relevant conditions that have been used 
extensively in our research group. Due to the native-state stability of the lysozyme variants, it 
is extremely challenging to make fibrils on a reproducible timescale, in vitro, using conditions 
which lend themselves to the study of how biomolecules modulate fibril formation. Over the 
years, a number of solution conditions have been successful for the formation of HuL and 
HEWL amyloid fibrils; however, for HuL, they have required harsh conditions including low 
pH with high temperatures and stirring [156, 160], moderate pH with high temperatures and 
the presence of denaturants [73] and physiological pH with high temperature and seeding [156]. 
The aggregation of HEWL, on the other hand, has been reported at pH 2 with high temperatures 
and stirring [161, 162], and at neutral pH with ethanol [163, 164], where the aggregation is 
more readily achieved after the reduction of the disulphide bonds [163]. Nevertheless, the 
recent investigations with I59T HuL [69] demonstrated that, for this variant, we could form in 
vitro fibrils in less than 24 h using relatively low concentrations of protein (7 μM, i.e. 0.1 
mg/mL), pH 5.0 and 60 ˚ C with stirring. These conditions, although at an elevated temperature, 
still allow for the inhibitory properties of biomolecules, such as extracellular chaperones e.g. 
haptoglobin, α2M, clusterin [69, 79] and camelid antibodies e.g. cAbHuL-5 (De Genst and co-
workers, unpublished), to be studied.  
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4.1.1. Chapter aims 
 
As introduced in Section 1.2.2, HuL oligomers formed prior to amyloid fibrils during 
aggregation, under our extensively used pH 5.0, 60 ˚C conditions, have not been fully 
characterised. Understanding the mechanistic details regarding the population of oligomeric 
species in the early stages of this aggregation pathway is imperative if we wish to be able to 
regulate or inhibit aggregation. It is also of great interest to investigate how the oligomer 
distribution during fibril formation of a globular protein compares to well-studied IDP systems. 
In this chapter, we will use the SM microscopy set-up optimised in Chapter 3 to not only 
identify the oligomeric populations present along the aggregation pathway but also to gain 
insights into the structure and population distribution of these species. 
 
4.2. Results 
 
In the previous chapter, we showed that HuL oligomers formed under stabilising acidic 
conditions can be detected using SM fluorescence microscopy. The optimised SM microscope 
was used in this chapter to detect oligomers formed under more physiologically relevant 
conditions (7 μM, pH 5.0, 60 ˚C). In order to do this, the aggregation of 7 μM Alexa-labelled 
I59T HuL (3.5 μM of each dye) in 0.1 M citrate buffer, pH 5.0 was followed by ThT 
fluorescence in a conventional fluorimeter (Figure 4.1), and the resulting fibrils were imaged 
by TEM (Figure 4.1, inset). Different time points were taken during the aggregation, put on ice 
to prevent oligomer dissociation, and injected into the microfluidic device. As observed in 
Figure 4.1, the lag phase lasts for 4-5 h, at which point, the ThT fluorescence increases until 
reaching a plateau that is observable from around 10 h. For this reason, the results of this 
chapter will focus on the first 12 h of fibril formation as the goal was to observe oligomers 
formed in the early stages of aggregation.  
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Figure 4.1. Fibril formation of Alexa-labelled I59T HuL as monitored by conventional 
fluorescence spectroscopy. Normalised ThT fluorescence of stoichiometric amounts of A488-
I59T and A647-I59T HuL in 0.1 M citrate buffer (pH 5.0), incubated with stirring at 60 ˚C. 
The lag phase ends at 4-5 h and a plateau is reached after approximately 10 h. The normalised 
data was calculated using unity-based normalisation, where each point is calculated as (x-
xmin)/(xmax-xmin) where x is the measured raw data, and xmin and xmax are the minimum and 
maximum values of the raw data, respectively. Inset: TEM image of the fibrils formed after 24 
h. The scale bar represents 100 nm.  
 
4.2.1. Characterisation of HuL oligomers by conventional methods 
 
Before moving on to using the Alexa-labelled I59T HuL to investigate the early stages of 
aggregation with SM techniques, we first looked to see if we could identify the presence of 
oligomeric species using conventional techniques, keeping in mind that the oligomer 
population was likely to be heterogeneous and present in very low concentrations. In order to 
probe for the presence of oligomers, we looked at the evolution of the structural conformation 
of the ensemble of species present. The fluorophores, ThT, pFTAA (described in Section 1.5.5) 
and 8-Anilino-1-naphthalenesulfonic acid (ANS) were used to monitor the change in β-sheet 
content (ThT and pFTAA) and in hydrophobicity (ANS) by measuring their fluorescence 
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emission at different time points during the aggregation process. ANS is a dye whose emission 
intensity has been shown to be proportional to the amount of exposed hydrophobic surfaces 
present [135, 165], and changes in its binding capabilities have been correlated to changes in 
cytotoxicity [89]. Therefore, ANS fluorescence provides a great tool for the direct evidence of 
the presence of exposed hydrophobic surfaces and its change over the course of the 
aggregation. The fluorescence emission of ANS for time points 0, 2, 5, 9 and 24 h was recorded 
in triplicate from 400 to 600 nm, after excitation at 350 nm, and the fluorescence maxima at 
475 nm were plotted over time (Figure 4.2, e). The time points were taken from a 7 μM I59T 
HuL aggregation reaction under pH 5.0, 60 ˚C conditions. The ANS fluorescence at 475 nm 
increases with time, which suggests that the amount of exposed hydrophobic surfaces increased 
after 2 h (Figure 4.2, e). The ThT fluorescence emission for the same time points is shown in 
Figure 4.2 (a) and (b). Similarly to ANS, ThT fluorescence shows a slight increase in emission 
between 0 and 5 h, followed by a significant increase after 9 h, which corresponds with fibril 
formation (Figure 4.1). These data suggest that there is an increase in the hydrophobicity and 
β-sheet content of the sample at the early time points of the aggregation reaction. This result is 
different to previous research on a globular system in which no ThT or ANS binding was 
detected for initial aggregates [166].  Detecting ANS fluorescence is, however, in agreement 
with the study of Bolognesi and co-workers, which showed a positive ANS signal during the 
lag phase of the aggregation reaction of I59T HuL, which also correlated with an increased loss 
in cell viability [89]. Interestingly, we see an increased ANS fluorescence for the fibrillar 
species, which was not observed in the previous study. An increase in ANS fluorescence was 
also observed previously for the early time points of WT HuL fibril formation at pH 3, 60 ˚C 
[167]. In the case of pFTAA, the fluorescence emission increased over time after 3.5 h (Figure 
4.2, c and d). The double-peak shape observed for the pFTAA fluorescence at later time points 
is characteristic of its binding to oligomers and fibrils [138]. In order to investigate whether a 
change in the secondary structure of I59T HuL could be detected as the aggregation proceeded, 
CD spectroscopy was used to scan the same time points. In order to minimise the concentration 
needed for the readings, a longer path length was used which, together with the citrate buffer, 
meant it was not possible to gain accurate spectra for the time points 2-9 h. Although the shape 
of the curve is not changing much, the intensity of the minima appears to change over time 
(Figure 4.3, a). The signals at 222 and 208 nm correspond to the presence of α-helical content 
whilst 215 nm generally corresponds to that of β-sheet [146]. The shape of the curve would 
undergo significant change if a significant conformational change towards β-sheet or random 
coil content could be observed [168]. After 24 h, the secondary structure of the sample shifted 
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from α-helical to β-sheet content (Figure 4.3, b). Although much less pronounced, this subtle 
change in secondary structure shown by CD spectroscopy is in agreement with the 
conformational change observed in previous studies of the globular systems of insulin [169], 
Sulfolobus solfataricus acylphosphatase (Sso AcP) [166] and an antibody domain [170], where 
their early time points of the aggregation process showed a significant conformational change 
that involved a disturbance in the 204-220 nm range, but yet the structure observed was native-
like. In addition, the transient intermediate populated by HuL, which we believe interacts 
through unfolded β-sheet regions to then form amyloid fibrils, may retain native-like structure 
within the α-domain [75]. The lack of an obvious significant conformational change compared 
to other studies by CD spectroscopy may be caused by a significantly smaller population of the 
early species than those yielded from other systems, or these species being more structurally 
similar to the native-state. Given the lowly populated nature of the putative oligomers, it is 
clear that further repeats of these investigations would be beneficial and that these data are 
merely suggestive and cannot be overly interpreted. 
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Figure 4.2./ Conventional biophysical characterisation of HuL oligomers in solution, 
formed at pH 5.0, 60 ˚C (I). a), b), c) and d) Fluorescence emission of ThT (a,b) and pFTAA 
(c,d) for time points 0 (black), 2 (red), 3.5 (orange), 5 (green), 9 (cyan), and 24 h (violet). The 
scale of the emission of ThT and pFTAA has been enhanced in (b) and (d), respectively, to 
observe clearly the time points 0 (black), 2 (red), 3.5 (orange), and 5 h (green). The 
fluorescence emission increases over time for both ThT and pFTAA. e) The normalised ANS 
fluorescence emission at 475 nm after 0 (black), 2 (red), 5 (green), 9 (cyan) and 24 h (violet) 
increases over time. f) Comparison of the normalised data for ANS (blue), ThT (orange) and 
pFTAA (green). The normalised data was calculated using unity-based normalisation, where 
each point is calculated as (x-xmin)/(xmax-xmin) where x is the measured raw data, and xmin and 
xmax are the minimum and maximum values of the raw data, respectively. The data for 0 and 
24 h were used as xmin and xmax, respectively. The data show the mean and the error bars 
represent the standard deviation from one set (ThT, pFTAA) and from two sets of triplicate 
measurements (ANS).  
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Figure 4.3. Conventional biophysical characterisation of HuL oligomers in solution, 
formed at pH 5.0, 60 ˚C (II). a) CD signal at time 0 (black), 2 (red), 3.5 (orange), 5 (green), 
and 9 h (cyan). The spectra show interference, most likely due to the use of a longer path length 
and citrate buffer. b) CD measurements for I59T HuL after 0 (black) and 24 h (violet) without 
interference. The spectrum after 24 h shows a minimum at 215 nm, which typically corresponds 
to the presence of β-sheet content. The data for the 0, 2, 3.5, 5, and 9 h time points in (a) and 0 
h in (b) show the mean and the error bars represent the standard deviation from one set of 
triplicate measurements. The data for the 24 h time points represents a single measurement.   
 
4.2.2. Characterisation of HuL oligomers using TCCD 
 
In order to characterise the species present in the early stages of fibril formation, TCCD was 
used to follow the aggregation of the Alexa-labelled I59T at picomolar concentrations. The 
time points were taken from the fibril formation reaction, diluted to 100 pM, injected into the 
microfluidic device and then infused at a flow rate of 0.61 cm s-1. The resulting data shows an 
increase in the total number of coincident events (which correspond to oligomers) over time 
(Figure 4.4, a). The detected species were divided into three different categories according to 
their apparent size: small (2-4 monomers), medium (5-20 monomers) and large (21-100 
monomers). The fraction of events corresponding to the medium and large oligomers increased 
over time, showing a significant fraction of large species (5-10%) from 9 h onwards (Figure 
4.4, b). The percentage of oligomeric species in the sample was calculated as described by 
equation 1.1 in Section 1.5.2 and multiplied by 100 for each time point, and it shows an increase 
over time until reaching a maximum of 0.7-0.8% after 13 h (Figure 4.4, c). This result is 
significant because it means that for every 100 monomers, there is less than one oligomer 
molecule and hence the concentration of the oligomers will be, in principle, at least 100-fold 
lower than that of the initial monomer concentration. Finally, the average size, given as the 
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approximate apparent size in monomers, was calculated and showed an increase only after 9 h 
of aggregation (Figure 4.4, d). This average size is not accurate, due to the many different paths 
a molecule can take through the confocal volume and the stochasticity of the photoswitching 
of single fluorophores [171], but it gives further insight into how the average size of the species 
present in the sample changes with time as well as providing a comparison to the size 
histograms shown in Figure 4.4 (a).  
 
 
Figure 4.4. Characterisation of I59T HuL oligomers as followed by TCCD. a) The number 
of coincident events increases with time. The species were divided into different apparent size 
categories where small (2-4 monomers), medium (5-20 monomers), and large oligomers (21-
100 monomers) are shown in blue, orange and green, respectively. The number of medium 
oligomers increases with time whilst large oligomers are detected from 9 h onwards. b) The 
fraction of medium species increases over time, accounting for 40% of events after 4 h (c.f. 
20% after 1 h). The fraction of large oligomers increases after 9 h, reaching a maximum of 
10% after 11 h. c) The percentage of oligomers present in the sample increases with time. d) 
The average size increases after 9 h. This estimation is not accurate due to the many different 
paths a molecule can take through the confocal volume and the stochasticity of the 
photoswitching of single fluorophores.  
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From these results, it can be concluded that HuL oligomers formed in the pH 5.0, 60 ˚C 
conditions are detectable at 100 pM by SM microscopy, which is in itself a significant result 
as it means these oligomers are stable after dilution to picomolar concentrations. In addition, 
an increase in the number and size of the oligomers is reported. These results encouraged us to 
monitor the aggregation using SM FRET to gain more insights into the oligomer structures.  
 
4.2.3. Characterisation of HuL oligomers using SM FRET  
 
As described in Section 1.5.3, for FRET to occur, the donor and acceptor fluorophores must be 
within 10 nm distance. For this reason, unlike for TCCD, there is no chance coincidence and 
thus, SM FRET allows for higher concentrations to be used. For this reason, the different time 
points from the Alexa-labelled I59T HuL fibril formation were diluted to 750 pM for the rest 
of the SM experiments reported in the remaining chapters. As described in Section 1.5.3, SM 
FRET involves only the use of the blue laser whose excitation wavelength, 488 nm, 
corresponds to that of the donor (A488). The data obtained from this technique provides insight 
about the number and apparent oligomer size as well as the oligomer structure (related to the 
FRET efficiency). A more structured, compact oligomer will generally show a higher FRET 
efficiency. Different time points were taken from a 7 μM Alexa-labelled I59T HuL aggregation 
reaction, diluted to 750 pM and injected into the microfluidic device. The FRET efficiency 
given by the data is shown in a 2D plot with a colour scale to represent the number of oligomers, 
in a logarithmic scale, over time (Figure 4.5). These data show that the size and FRET 
efficiency as well as the total number of events detected increase with time. After 2 h, the 2D 
plot shows that the FRET efficiencies observed for the species of apparent sizes smaller and 
larger than 10 monomers are clearly distinct (Figure 4.5, b). The region of 2-10 monomers 
shows a broad range of FRET efficiencies that span from approximately 0.2 to 0.6, whereas 
the species larger than 10 monomers are detected at FRET efficiencies exclusively in the range 
of 0.6-0.7. These two distinct regions are observed for every time point until 9 h, when the 
lower FRET efficiency region virtually disappears (Figure 4.5, e), making the small oligomers 
almost indistinguishable from the large oligomers in terms of their FRET efficiency after 9-12 
h (Figure 4.5, f). This result suggests that an oligomer may only be able to reach a certain size 
in a highly structured manner. Two main conclusions can then be drawn from these data: first, 
the oligomeric population can be divided in two distinct populations, small (apparent size of 2-
10 monomers per oligomer) and large (10-150 monomers). Anything bigger than 150 
monomers was ignored for this analysis as only pre-fibrillar species are of interest in this study. 
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This division also considers the observed FRET efficiency, as small oligomers show both low- 
and high-FRET and large oligomers only show high-FRET. Secondly, the population of small 
low-FRET oligomers appears to decrease with time until virtually disappearing after 12 h, 
when only high-FRET species are detected. The reason for this decrease may be explained 
either by these oligomers dissociating back to monomers, or by undergoing a conformational 
change to then convert into high-FRET oligomers. In order to find out more about these 
oligomer populations, the numbers of small and large oligomers were plotted against their 
FRET efficiencies (Figure 4.6). For small oligomers, there are two clearly distinct populations 
as per their FRET efficiencies, one population centred at a FRET efficiency of 0.2-0.3 and the 
second one centred at 0.6-0.8 (Figure 4.6, a). The number of low-FRET oligomers is highest 
after 2 h whereas the number of high-FRET oligomers is highest after 9 h (Figure 4.6, a). The 
time points between 2 and 9 h show a wider FRET efficiency distribution, which may be 
explained as the sum of two populations or as one population centred at approximately 0.5. 
Nevertheless, given the data for the earlier and later time points, the distribution observed for 
time points 3-8 h is more likely explained by the presence of two populations, where the low-
FRET and high-FRET populations are those predominantly detected after 2 h and 9 h, 
respectively. The number of large oligomers increases with time and only one peak at a FRET 
efficiency of 0.6-0.8 is observed (Figure 4.6, b).  
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Figure 4.5. SM FRET 2D plots showing FRET efficiencies and oligomer size. The apparent 
size of the oligomers (in number of monomers) is plotted against their FRET efficiency for 
different time points of the aggregation of Alexa-labelled I59T HuL. Both the size and FRET 
efficiency increase over time. a) 0 h. b) 2 h. c) 5 h. d) 7 h. e) 9 h. f) 12 h. 
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Figure 4.6. Evolution of the distribution of I59T HuL oligomer populations by counts and 
FRET efficiency. The oligomers were separated into two different size populations: a) small 
(apparent size of 2-10 monomers), and b) large oligomers (apparent size of 10-150 monomers). 
The size classification for these two oligomer populations was chosen to have the minimum 
number of unique oligomer populations whose FRET histograms showed the minimum number 
of Gaussian distributions as detailed in reference [42]. For small oligomers, a shift towards 
higher FRET efficiencies is observed over time. The data for time points 2, 5, 6, 7, 9, and 12 h 
are shown in red, orange, yellow, green, cyan, and violet, respectively. The normalised data is 
shown to help visualise the shift in FRET efficiency. The data show the mean and the error 
bars represent the standard deviation from three independent experiments. The normalised data 
was calculated using unity-based normalisation, where each point is calculated as (x-
xmin)/(xmax-xmin) where x is the measured raw data, and xmin and xmax are the minimum and 
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maximum values of the raw data, respectively. b) Only one peak is observed for large oligomers 
(FRET efficiency equal to 0.6-0.8). The data for time-points 0, 2, 5, 6, 7, 9, and 12 h are shown 
in black, red, orange, yellow, green, cyan, and violet, respectively. The number of large 
oligomers increases with time.  
 
Next, the population distributions for small oligomers were fitted to a two peak Gaussian in 
OriginPro 9.1, using the expression  
 
y = y
0
 + 
Ae
- (x - x𝑐1)
2𝑤12
2
𝑤1 × sqrt (
π
2
)
 + 
(1-A)e
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2𝑤22
2
𝑤2 × sqrt (
π
2
)
  (Eq. 4.1) 
 
where y0 is the base of the curve, A is the amplitude, and xc and w are the centre and width for 
each of the distributions, respectively. Prior to this fitting to monitor the evolution of each of 
the oligomer populations over time, both the centre and width for each population were 
identified for all incubation times using the sum of two Gaussian distribution curves in 
OriginPro 9.1. The representative centres and widths were chosen from time point 4 h (Figure 
4.7), as the population distributions at this time were representative enough for those detected 
at every time point, and the parameters were calculated to be 0.34 ± 0.01 and 0.60 ± 0.01 for 
the centres, and 0.217 ± 0.012 and 0.202 ± 0.014 for the widths for the low-FRET and high-
FRET populations, respectively. The centres and widths were then kept fixed for the fitting of 
each time point in order to limit each population and accurately monitor their evolution over 
time. These parameters have physical meaning, as about 68% of oligomers of said populations 
will fall within the mean (centre) ± the standard deviation (width) of the distribution. The 
fittings for different time points have been shown in Figure 4.8. The colours used in this figure 
correspond to the colours in Figure 4.6 (a) for the same time points. It can be concluded from 
the data that low-FRET oligomers were formed first within 2 h of aggregation. As this 
population shifts towards higher FRET efficiencies over time, the low-FRET population 
decreases until disappearing completely after 12 h, when the fitting is unviable as the low-
FRET population was not detected (Figure 4.8, f). This data further indicates that the low-
FRET oligomers may be experiencing a conformational transformation to form the more 
structured high-FRET population during the aggregation.  
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Figure 4.7. Normalised number of oligomers as a function of FRET efficiency for time 
point 4 h. The data were fitted to a sum of two Gaussian curves (black line) from which the 
centres of each population were calculated to be 0.34 ± 0.217 (green line) and 0.60 ± 0.202 
(red line). The data show the mean and the error bars represent the standard deviation from 
three independent experiments. 
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Figure 4.8. Evolution of small oligomers over time. a) 2 h (red). b) 5 h (orange). c) 6 h 
(yellow). d) 7 h (green). e) 9 h (cyan). f) 12 h (violet). The distribution of the population after 
2 h is centred at a FRET efficiency of approximately 0.3, which then shifts towards higher 
FRET efficiencies until 9 h, when it is centred at approximately 0.6 (e). The data show the 
mean and the error bars represent the standard deviation from three independent experiments. 
The fittings represent the sum of two Gaussian curves (black) of which one corresponds to low-
FRET oligomers (green line, centre fixed at 0.34 ± 0.217 for all time points) and the other one 
corresponds to high-FRET oligomers (red line, centre fixed at 0.60 ± 0.202 for all time points).  
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The process just described above allows for the monitoring of multiple populations, and the 
amplitude of the resulting Gaussian curves can be used to calculate the fraction of small low-
FRET and high-FRET oligomers using the expression  
 
p
i
 = 
Ai
AL + AH
  (Eq. 4.2) 
 
where pi is the proportion or fraction of the population of interest (small low-FRET or high-
FRET oligomers); Ai is the amplitude of the Gaussian distribution for the population of interest 
(small low-FRET or high-FRET oligomers); and AL and AH are the amplitudes of the low-
FRET and high-FRET Gaussian distributions, respectively.  
 
The fraction of small low-FRET oligomers was calculated using Eq. 4.2 and it decreases over 
time, and it was calculated to be approximately 90% after 2 h and 0% after 11 h, which in turn 
means that the high-FRET population increased from being lower than 10% after 2 h to 100% 
after 11 h (Figure 4.9, c). After 5 h, the fraction of high-FRET oligomers exceeds that of low-
FRET for the first time. The fraction of the populations remains constant at approximately 50% 
after 5-7 h of aggregation (Figure 4.9, c). These proportions may be related to the rates of 
formation and depletion of both populations, as the low-FRET oligomers either dissociate into 
monomers or convert into high-FRET oligomers and the latter elongate in turn to form larger 
oligomers and eventually fibrils. The number of small low-FRET and high-FRET oligomers 
can then be calculated by simply multiplying each of the calculated fractions by the total 
number of small oligomers (Figure 4.9, a). The number of small low-FRET oligomers increases 
during the first 2 h of aggregation and then decreases until disappearing after 12 h, whereas the 
number of small high-FRET oligomers increases over the course of the aggregation (Figure 
4.9, a). On the other hand, the population of large high-FRET oligomers increases over time, 
whilst the number of large low-FRET oligomers remains effectively zero throughout the 
aggregation reaction (Figure 4.9, b). In order to follow the shift of the oligomer population over 
time, the population distribution for each time point was fitted to one-peak and two-peak 
Gaussian curves, without putting any constraints on the centre or width of each curve. The one-
peak fitting shows a shift towards higher FRET efficiencies over time, which correlates to the 
detection of more structured and compact species (Figure 4.9, d). The two-peak fitting shows 
two relatively constant populations that were clearly distinct, as per their FRET efficiencies, 
showing one population being centered at a FRET efficiency of 0.3-0.35, with another at 
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approximately 0.6 (Figure 4.9, e). As the low-FRET oligomers completely disappear after 11-
12 h, the two-peak fitting becomes unsuitable (as only one peak is observed) and hence the 
fitting shows a large error for time points 11-12 h (Figure 4.9, e). As mentioned only 
descriptively for Figure 4.6, after quantitative analysis the two-peak Gaussian curve fittings 
describes the data more accurately as it accounts for the change in the oligomer populations as 
it shifts from populating mostly the low-FRET species after 2 h to populating mostly the high-
FRET species after 9 h, whereas a one-peak Gaussian curve cannot describe this shift (Figure 
4.9). From this analysis, it can be concluded that as the small low-FRET oligomer population 
decreases, the small high-FRET oligomer population increases and therefore, we hypothesise 
that this result is most likely explained by the conversion of small low-FRET to high-FRET 
oligomers over time.   
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Figure 4.9. Evolution of low-FRET and high-FRET populations over time. a) Number of 
small low-FRET (green) and high-FRET (red) oligomers over time. The number of low-FRET 
oligomers increases for the first 2 h and then decreases over time, whereas the number of high-
FRET oligomers increases over time. b) Number of large low-FRET (green) and high-FRET 
(red) oligomers over time. No large low-FRET oligomers were detected over the course of the 
aggregation, and the number of large high-FRET oligomers increases over time. c) Fraction of 
small low-FRET and high-FRET oligomer population over time. The fraction of low-FRET 
oligomers (green) decreases over time whereas the fraction of high-FRET oligomers (red) 
increases over time. After 5 h, the high-FRET population exceeds the low-FRET one. Both 
populations remain at approximately 50% from 5-7 h. d), e) Change in FRET efficiency over 
the course of aggregation. The oligomer distribution for each time point was fit to a one-peak 
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(d) and two-peak (e) Gaussian curve and the value of the peak was then plotted over time. The 
FRET efficiency of the population increases over time for the one-peak fitting, whereas for the 
two-peak fitting the low-FRET and high-FRET populations remain relatively constant and 
centred at 0.3-0.35 and 0.6, respectively. The error at 11-12 h for the two-peak fitting can be 
explained by the existence of only one peak and hence making this fitting unsuitable for these 
two time points. The data show the mean and the error bars represent the standard deviation 
from three independent experiments.  
 
4.2.4. Fitting SM FRET data to a kinetic model 
 
In order to further understand the mechanistic details of HuL fibril formation, the data obtained 
using SM FRET in the section above were modelled and used to calculate different kinetic 
parameters. For this purpose, the numbers of oligomers of the three populations identified in 
the previous section (small low-FRET and high-FRET, and large high-FRET) were converted 
into concentrations. To do this, the fraction of oligomers was calculated as the number of 
oligomers divided by the average monomer count for the first 5 h of aggregation, when fibrils 
have not yet formed and hence monomer depletion can be ignored (Figure 4.1). The monomer 
count was calculated by multiplying the donor count by 2, as only the monomers labelled with 
A488 are visible in SM FRET experiments. The fraction of oligomers was then multiplied by 
the initial monomer concentration (7 μM) to obtain an estimate of the oligomer concentration. 
One of the limitations of this calculation is that the number of events, for both monomers and 
oligomers, is dependent on the intensity threshold applied on the analysis of the SM data. 
Nevertheless, this method to calculate oligomer concentration from SM microscopy data is 
widely applied [29, 40, 43], and the calculated concentrations are in agreement with the range 
of oligomer concentrations reported in the literature for other protein systems, when initial 
monomer concentrations in the low μM range were used [29]. The concentrations of the three 
different populations were then plotted against time (Figure 4.10), which shows that small and 
large high-FRET oligomers show the same kinetic behaviour, and therefore they will be 
considered as one oligomer type for the kinetic modelling in this section (Figure 4.11). 
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Figure 4.10. Oligomer concentration calculated from SM FRET data over time. The 
concentration of the small low-FRET oligomers is shown in green, and small and large high-
FRET oligomers in red and orange, respectively. Both small and large high-FRET species show 
the same kinetic behaviour over time. The data show the mean and the error bars represent the 
standard deviation from three independent experiments.  
 
The data were then fitted to a simple kinetic model, similar to that shown in references [29, 42-
44] (Figure 4.11). From the ThT experiments performed in a fluorimeter under the same 
reaction conditions as the SM FRET experiments (Figure 4.1), we know that HuL monomer is 
not significantly depleted until after 5 h; therefore, we can utilise an early-time kinetic model, 
in which the monomer concentration is constant, up until this time point. This is advantageous 
since we do not know the mechanism by which monomer is depleted, and thus cannot devise 
a kinetic model that includes this phenomenon. Writing L(t) for the concentration of the low-
FRET species, and H(t) for the high-FRET species, the rate equations under constant monomer 
conditions are 
 
dL
dt
 = α - (kc + kd) L(t)  (Eq. 4.3) 
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dH
dt
 = kc L(t)  (Eq. 4.4) 
 
where α is the rate of formation of low-FRET oligomers from monomer, and likely depends 
on monomer concentration as α = koligom(0)
2, kcL(t) is the rate of formation of high-FRET 
oligomers from low-FRET oligomers, and kd is the rate constant of the dissociation of low-
FRET oligomers. Note that kc is a pseudo-rate constant that may in fact have monomer 
dependence, but this cannot be determined under constant monomer conditions. Therefore, we 
cannot say for certain that the formation of high-FRET from low-FRET oligomers is a true 
unimolecular conversion reaction.  
 
No depletion processes for high-FRET oligomers are included in this model because there is 
no evidence of high-FRET oligomer depletion: even after 5 h, when both monomer and low-
FRET oligomer concentrations are decreasing, there is no decrease in high-FRET oligomer 
concentration. Moreover, the delayed appearance of high-FRET oligomers is evidence that they 
form from low-FRET oligomers and not directly from monomers. The model equations can be 
solved exactly analytically, yielding 
 
L(t) = 
α
ke
 (1 - e-ket)  (Eq. 4.5) 
 
H(t) = 
αkc
ke
2
 (ket + e
-ket - 1)  (Eq. 4.6) 
 
where ke = kc + kd. This model fits the data reasonably well given the level of experimental 
variation, and yields the parameter values α = 0.6415 nM h-1, ke = 1.1209 h-1, and kc = 0.1858 
h-1. We see that although the model is only fitted to the data up to t = 5 h, these parameters are 
also consistent with the observed behaviour after t = 5 h. Namely, a relatively rapid 
equilibration of monomers and low-FRET oligomers, shown by the relatively high α and kd, 
explain the relatively rapid drop-off in low-FRET oligomer concentration after t = 5 h, when 
monomer is depleted. The reduction in L(t) after t =  5 h is also consistent with a decrease in 
the rate of H(t) formation. A notable result of the modelling is that kd>>kc, i.e. low-FRET 
oligomers are approximately 5 times more likely to dissociate than to convert into high-FRET 
species. This is different to the results shown in references [29, 42-44], in which αS data fit 
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well to a model with no dissociation. The relatively rapid plateauing and decline of L(t) here 
cannot be explained by such a model, in which all L(t) loss is due to conversion to H(t). 
However, this result is, in fact, in line with all studies of oligomers formed by non-αS proteins 
[30, 31]. We thus have a distinction between unstable disordered low-FRET oligomers and 
later-forming, more structured and more stable high-FRET oligomers. 
 
Figure 4.11. Kinetic traces for the different oligomer populations over time. Low-FRET 
species are shown in green and high-FRET species, in red. The data was fitted to an early-time 
kinetic model, over the first 5 h, when the monomer concentration is constant and there is no 
fibril formation (in accordance to ThT fluorescence in Figure 4.1). The data show the mean 
and the error bars represent the standard deviation from three independent experiments.  
 
4.2.5. SM fluorescence characterisation of HuL oligomers using extrinsic dyes 
 
Following the study of Alexa-labelled I59T oligomers, we wished to explore the use of label-
free SM microscopy, for the reasons described in Section 3.2.7, using ThT and pFTAA as the 
extrinsic dyes to detect label-free I59T HuL oligomers at μM concentrations. As described in 
Section 1.5.5, whilst ThT is the dye most commonly used to monitor protein aggregation, 
pFTAA has been shown to bind aggregates earlier than ThT in the aggregation process of 
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amyloid-β [138]. Thus, we decided to use both dyes as the extrinsic dyes, for comparison. The 
samples taken at different time points during fibril formation of I59T HuL were diluted to 1 
μM and then mixed with either pFTAA or ThT to a final dye concentration of 30 nM and 0.5 
μM, respectively. The mixture was then injected into the microfluidic device, and infused at a 
flow rate of 0.61 cm s-1. The data obtained from the experiments using pFTAA as the extrinsic 
dye shows an increase in the total number of pFTAA-active species over the first 8 h of 
aggregation (Figure 4.12, a). To further analyse the population distribution, the number of 
species was divided evenly into 5 different intensity ranges, and the results show that all 
intensity ranges increase in numbers with time (Figure 4.12, a). The selection of the intensity 
ranges was made by dividing the difference between the maximum and the minimum intensities 
by 5, and then including the same number of intensities per intensity range. The number 5 was 
chosen to minimise the number of intensity ranges whilst still allowing for the detection of any 
changes in the distribution of the intensity measured over time. The fraction of high intensity 
species increases with time, accounting for 40-50% of the detected species from 2 h onwards 
(Figure 4.12, b). The total intensity also shows an increase over time (Figure 4.12, c).  The total 
intensity is the sum of the intensities of all the pFTAA fluorescent bursts detected over the 
course of the measurement. The average intensity is calculated as the total intensity divided by 
the number of species and hence, it is the increase in the number of events and the total intensity 
that leads to the increase in average intensity within the first 2 h (Figure 4.12, d). This data 
shows that pFTAA can be used to detect label-free oligomers, formed under physiologically 
relevant conditions, present at μM concentrations (assuming the dilution as a function of the 
initial monomer concentration). In addition, the increase in the intensity of individual events 
can result from either an increase in size or an increase in β-sheet content. The cause of this 
increase could be discerned by further analysis using fluorophore-labelled protein and 
monitoring the ratio of pFTAA intensity to that of the fluorophore over time, as the intensity 
of the fluorophore is proportional to size and not to β-sheet content. 
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Figure 4.12. SM characterisation of I59T HuL oligomers using pFTAA as an extrinsic 
dye. a) The number of total pFTAA-active species increases with time. The number of species 
was classified into different intensity ranges with blue being 50-110 photon counts; red, 110-
170; orange, 170-230; yellow, 230-290; and green, 290-350. The number of species in all 
intensity ranges increases over time. b) The fraction of higher intensity oligomers increases 
over time. c) The total intensity increases over time. d) The normalised average intensity 
appears to increase after the first 2 h, and it was calculated using unity-based normalisation, 
where each point is calculated as (x-xmin)/(xmax-xmin) where x is the measured raw data, and xmin 
and xmax are the minimum and maximum values of the raw data, respectively.  
 
When ThT was used as the extrinsic dye, the resulting data shows an increase in the number of 
ThT-active species with time (Figure 4.13, a), albeit the increase appears to be less smooth than 
the data obtained for pFTAA (Figure 4.12, a). Nevertheless, ThT shows a clear difference 
before and after 6 h, which correlates with the ThT fluorescence shown in the conventional 
fluorimeter assay (Figure 4.1). After 1 h, the number of ThT-active species deviates from that 
of the time points directly before and after and this is likely due to an error in the measurement 
and not related to the sample after 1 h being significantly different. However, these experiments 
would need to be repeated for further confirmation. To analyse the population distribution 
further, the ThT-active species were divided evenly into 5 intensity ranges, which were chosen 
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as described above (Figure 4.13, a and b). Although an increase in the number of high intensity 
species is observed (Figure 4.13, a), there appears to be no trend for the fraction of these species 
over time (Figure 4.13, b). This may be explained by a similar rate of formation of the ThT-
active species regardless of their detected intensity. The total intensity remains relatively 
constant until approximately 6 h when it appears to increase (Figure 4.13, c). The average 
intensity did not show any distinct trend over the course of aggregation (Figure 4.13, d), which 
may be explained by the fluctuations in the total intensity data as well as in the total number of 
species detected, as the average intensity is calculated as the division of the two. Nevertheless, 
this data shows that ThT, like pFTAA, can be used to detect label-free HuL oligomers formed 
under physiologically relevant conditions using SM microscopy when diluted to a protein 
concentration of 1 μM.  
 
  
Figure 4.13. SM characterisation of I59T HuL oligomers using ThT as an extrinsic dye. 
a) The number of total ThT-active species appears to be constant until 6 h, after which it 
increases with time. The number of species was evenly divided into intensity ranges with blue 
being 80-130 photon counts; red, 130-180; orange, 180-230; yellow, 230-280; and green, 280-
330. The number of species in all intensity ranges increases after 6 h. b) The fraction of higher 
intensity species does not show a clear trend over time, which may be explained by the rate of 
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formation of the ThT-active species being similar regardless of their intensity. c) The total 
intensity increases after 6 h. d) The normalised average intensity does not show a clear trend. 
The normalised average intensity was calculated using unity-based normalisation, where each 
point is calculated as (x-xmin)/(xmax-xmin) where x is the measured raw data, and xmin and xmax 
are the minimum and maximum values of the raw data, respectively. 
 
The results shown in this section can be compared to the fluorescent signal shown by 
conventional fluorescence spectroscopy (Figure 4.14). The total intensity observed for ThT 
using SM microscopy follows the same trend as that measured in bulk with a fluorimeter. The 
fluorescence of pFTAA measured in bulk with a fluorimeter shows a steep increase after 1 h, 
whereas the increase in the total intensity observed using SM is gradual. This recording of 
pFTAA fluorescence in bulk has only been done once and therefore needs repeating. 
Nevertheless, the results shown in this section confirm that using extrinsic dyes to monitor 
fibril formation by SM microscopy, unlike the ensemble measurements performed by 
conventional methods, allows for more insight to be gained about the species formed during 
the aggregation reaction, as it reports on the number of dye-active species and their intensity 
distributions over time as shown previously in reference [134]. 
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Figure 4.14. Comparison of ThT and pFTAA fluorescent signals as monitored by SM 
microscopy and fluorescence spectroscopy. a) Normalised ThT intensity as detected by SM 
microscopy (orange) and by conventional fluorescence spectroscopy (black). b) Normalised 
pFTAA intensity as detected by SM microscopy (orange) and by conventional fluorescence 
spectroscopy (black). The normalised data was calculated using unity-based normalisation, 
where each point is calculated as (x-xmin)/(xmax-xmin) where x is the measured raw data, and xmin 
and xmax are the minimum and maximum values of the raw data, respectively. 
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4.3. Conclusion and next steps 
 
In this chapter we explored the characterisation of HuL oligomers formed in pH 5.0, 60 ˚C 
conditions, the more physiologically relevant conditions already widely used in our group and 
reported in the literature [67, 69, 145]. The characterisation of the early species present in the 
aggregation process was explored using conventional techniques (ANS, ThT, and pFTAA 
fluorescence, and CD spectroscopy). The results show positive ANS, ThT and pFTAA signals 
after 2 h (ANS and ThT) and 3.5 h (pFTAA). The data suggests that exposed hydrophobic 
surfaces are present as early as 2 h into the aggregation and that these species possess enough 
β-sheet structure to significantly bind with ThT. The CD data shows interference for time points 
2, 5 and 9 h, which may be caused by the use of a longer path length and citrate buffer. 
Nevertheless, the secondary structures recorded for the different time points seem to remain 
very much native-like, similar to that observed for other globular systems [166, 169, 170].  
 
Next, TCCD was used to investigate the oligomer population at picomolar concentrations. The 
data at 100 pM shows that both the number of oligomers and their size increase with time. The 
percentage of oligomers increases up to a maximum of 0.7-0.8% after 13 h. This low percentage 
of oligomeric species throughout the aggregation reaction may explain why the structural 
changes observed by CD spectroscopy were subtle and hard to discern. Following the results 
from TCCD, the structural properties of the oligomers were further explored using SM FRET. 
The results from this technique confirm that oligomers are formed within 1-2 h. The oligomer 
population was segmented by apparent size into small (2-10 monomers) and large (10-150 
monomers). The data shows two types of small oligomers as per their FRET efficiencies (low-
FRET and high-FRET population distributions). The low-FRET population distribution is 
centred at a FRET efficiency of 0.2-0.3, and its population increases within the first 2 h of 
aggregation and then decreases until disappearing completely after 11-12 h. The high-FRET 
population distribution is centred at a FRET efficiency of 0.5-0.7, and its population, unlike 
that of small low-FRET oligomers, remains present after 12 h. The population of large 
oligomers increases over time, and it shows a FRET efficiency distribution centred at 0.6-0.7 
which suggests that these species are highly structured and compact. The earlier formation of 
small low-FRET oligomers may be explained by hydrophobic interactions forming more 
readily than β-sheet structure, in which hydrogen bond interactions take longer to form. In 
addition, the lack of large low-FRET oligomers suggests that a conformational change from 
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low-FRET to high-FRET is needed for the oligomers to be growth-competent. This type of 
prerequisite has been reported before for tau oligomers [33]. Finally, the data from SM FRET 
were fitted to an early-time kinetic model where the rate of formation of low-FRET oligomers 
(α), the pseudo-rate constant of formation of high-FRET oligomers from low-FRET oligomers 
(kc), and the rate constant of dissociation of low-FRET oligomers (kd) were calculated to be α 
= 0.6415 nM h-1, ke = 1.1209 h
-1, and kc = 0.1858 h
-1. Interestingly, this indicates that low-
FRET oligomers are approximately 5 times more likely to dissociate than to continue along the 
aggregation pathway to form high-FRET oligomers.  
 
Once Alexa-labelled I59T HuL oligomers were confirmed to be detectable using the SM 
microscopy set-up, we used label-free SM microscopy methods involving the fluorophores 
ThT and pFTAA to determine whether the label-free oligomers could be detected upon dilution 
for SM analysis (in this case, to μM concentrations). Both ThT and pFTAA show the presence 
of oligomers at 1 μM (calculated as initial monomer concentration) which implies that the 
oligomers are stable enough after dilution. In addition, the data from the experiments with 
pFTAA shows that both the number and the size and/or the β-sheet content of the oligomers 
increase over time, whereas the data from the experiments with ThT shows that the number of 
species increases significantly only after 6 h. These results suggest that pFTAA may be 
reporting on the early-formed small oligomers whereas ThT may be reporting only on the large 
oligomers formed later in the aggregation reaction. Further repetitions would be needed as well 
as, as described before, further analysis using fluorophore-labelled protein and monitoring the 
ratio of pFTAA or ThT intensity to that of the fluorophore over time may make it possible to 
discern whether the increase in intensity observed is due to larger oligomer sizes or higher β-
sheet content. This label-free method has recently been used to estimate the fragmentation rate 
of αS aggregates, a key process behind the multiplication of pathological aggregates [134], and 
therefore further analysis could involve the kinetic fitting of ThT and pFTAA data for I59T 
HuL.  
 
In order to further explore the relevance and roles of these different oligomer populations in 
the HuL fibril formation, the next steps will include the study of their interaction with different 
biomolecules, and this will be explored in Chapter 5. In addition, different cell assays could be 
used to investigate the cytotoxicity of these oligomer populations and whether any differences 
can be observed on cellular toxicity.  
 
 Chapter 5: Characterisation of the 
interactions of HuL oligomers with the 
extracellular chaperone clusterin using SM 
fluorescence microscopy 
 
5.1. Introduction 
 
Understanding the role of different biomolecules on protein homeostasis is crucial if we want 
to be able to control and prevent the aggregation of proteins in the body. In order to do so, it is 
vital to further understand the mechanism of interactions that these biomolecules have with 
different species along the aggregation pathway.  
 
5.1.1. Extracellular chaperones and their role in disease 
 
Chaperones are proteins that help regulate protein homeostasis inside or outside the cell by 
assisting with the refolding of misfolded proteins to their native-state [172]. Chaperones can 
be found inside the cellular space e.g. chaperonins [173, 174], heat shock protein 90 (Hsp90) 
[175], and heat shock protein 70 (Hsp70) [176],  and also in the extracellular space e.g. clusterin 
[69, 177], and α2M [95, 178]. Although both types of chaperones have a great variety of 
functions inside and outside of the cell, it is their capacity to inhibit or regulate protein 
aggregation that is most interesting in the context of this thesis. As described before in Section 
1.3, it is currently thought that oligomers are the most toxic aggregate species towards cells 
[18], and that this is probably due to their exposed hydrophobicity [87, 89-91]. It is also 
currently believed that extracellular chaperones regulate aggregation by interacting with pre-
fibrillar species early in the aggregation process [69, 79] and they do this, most likely, through 
hydrophobic interactions with the same exposed amino acid residues of the oligomers that are 
thought to be responsible for their toxicity [179]. Extracellular chaperones like clusterin, α2M 
and haptoglobin have been found to reduce the cytotoxicity of these species to cells [92, 94, 
180]. A study using SM fluorescence also reported that clusterin forms soluble, stable 
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complexes with the aggregating protein implicated in Alzheimer’s disease, amyloid-β, and in 
doing so it prevents fibril formation [90]. Another study found that clusterin and α2M induce 
oligomers to form larger species, thereby reducing the overall toxicity of the oligomers [92]. 
Although these two chaperones have also been found to reduce the toxicity of amyloid-β 
oligomers [181, 182], other research reported an increase in toxicity when they are present 
during amyloid-β aggregation [93, 183]. Given this evidence, it is believed that the effect of 
extracellular chaperones in aggregation can be dependent on the condition details, such as the 
ratio of chaperone to protein of interest [179].  
 
5.1.2. Clusterin and its role as an extracellular chaperone  
 
As introduced in the previous section, clusterin is an extracellular chaperone present in blood 
plasma and cerebrospinal fluid in the human body [184]. Clusterin has a variety of functions 
including protease inhibition [185] and regulation of lipid transport [186], and it has also been 
shown to have a role in disease [179]. The expression of clusterin is upregulated for different 
conditions such as Alzheimer’s disease [187, 188] and diabetes [189] and it has been found to 
co-localise with the protein deposits found during disease [190-193].  In addition, clusterin has 
been shown to inhibit protein aggregation in vitro [69, 90, 91, 94, 194] and in vivo [195, 196]. 
Although the role of clusterin in disease is not yet fully understood [179], the literature shows 
that clusterin interacts with pre-fibrillar species, rather than with monomers or mature fibrils 
when having an impact on aggregation [69, 90, 94]. Kumita and co-workers investigated the 
influence of clusterin on HuL fibril formation [69] and showed that clusterin significantly 
inhibited the aggregation, and yet it did not interact with HuL in the monomeric and fibrillar 
states. In addition, HuL was still able to populate the transient partially-unfolded intermediate 
necessary for fibril formation [58, 197], and therefore the study concluded that clusterin must 
interact with oligomeric species present during the lag phase of HuL aggregation [69].  
 
5.1.3. Chapter aims 
 
In this chapter, we would like to revisit the ability of clusterin to inhibit HuL fibril formation 
using our newly acquired ability to identify oligomer populations of HuL using SM 
fluorescence. By examining the in vitro interactions between the extracellular chaperone 
clusterin and HuL oligomers, we will attempt to gain structural insight about what is truly 
occurring during the inhibition process.  
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5.2. Results 
 
In Chapter 4, we showed the distinct oligomer populations present in the early stages of I59T 
HuL fibril formation. Due to the extensive research done previously on the role of clusterin in 
HuL aggregation and other systems [41, 69, 91, 94], we decided to further explore whether our 
newly established analysis of the lag phase of HuL aggregation could be used to further 
understand the mechanistic details of the interactions of these oligomer populations with 
relevant biomolecules, specifically, clusterin. 
 
5.2.1. Characterisation of HuL fibril formation in the presence of clusterin using 
conventional methods 
 
The aggregation of HuL in the presence of clusterin was reproduced from reference [69]. The 
aggregation was followed by light scattering at 500 nm and, whilst I59T HuL alone showed 
the classical sigmoidal growth, the sample with clusterin (1:10 clusterin-to-lysozyme molar 
ratio) did not (Figure 5.1, a). The resulting aggregates were imaged by TEM (Figure 5.1, b and 
c). Kumita and co-workers showed that clusterin forms a small amount of non-fibrillar 
aggregates when incubated alone in the pH 5, 60 ˚C conditions [69]. Therefore it is clear that 
clusterin is destabilised in these conditions, but it still retains inhibitory capabilities as shown 
by the kinetic assays and the TEM images. In fact, clusterin is still effective at inhibiting protein 
aggregation when present at 1:40 clusterin-to-lysozyme ratio under these conditions [69], 
where clusterin is about 50% unfolded as its melting temperature is ~45 ˚C (Kumita, 
unpublished results). Therefore, these results suggest that the inhibitory effect of clusterin is 
not related to its native structure as such. This conclusion is reinforced by the fact that its 
structure is not well known and some of its regions are considered intrinsically disordered, 
which is consistent with the current belief that it interacts with client proteins through 
hydrophobic interactions [179].   
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Figure 5.1. Characterisation of I59T HuL aggregation in the presence and absence of 
clusterin. Clusterin was present at a clusterin-to-lysozyme ratio of 1:10. a) Light scattering 
monitored at 500 nm. The curve for I59T HuL alone (black) shows the characteristic 
exponential growth after approximately 5 h and then reaches a plateau after 10 h. The curve 
for I59T HuL in the presence of clusterin (pink) does not show significant growth on this 
timescale. b), c) TEM images of the aggregates after 24 h for I59T HuL in the absence (b) and 
in the presence (c) of clusterin. The scale bar represents 100 nm. These data correlate well to 
those shown in reference [69].  
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5.2.2. Characterisation of the interactions of HuL oligomers with clusterin using SM 
FRET 
 
Once the protocol for the aggregation in bulk was successfully reproduced, different time 
points along the aggregation pathway (0-12 h) were diluted to 750 pM, injected into the 
microfluidic device and flowed through the SM microscopy set-up at a flow rate of 0.61 cm s-
1. The apparent size of the oligomers was plotted against their FRET efficiency in a 2D plot for 
each time point. After 2 h, the FRET efficiencies shown by small oligomers (apparent size of 
2-10 monomers) span from 0.3 to 0.7 (Figure 5.2, b), which is similar to the result obtained for 
the same time point in the absence of clusterin (Figure 4.5, b). However, the large oligomers 
detected after 2 h (apparent size of 10-150 monomers) appear at a much broader range of FRET 
efficiencies when compared to I59T HuL alone. The population distribution appears to be 
relatively unchanged until 7 h, after which the number of oligomers decreases for time points 
8-12 h. Although small oligomers show a similar distribution as per their FRET efficiencies as 
compared to the results of I59T HuL in the absence of clusterin, this data suggests that, in the 
presence of clusterin, the formation of large oligomers does not necessarily result in a highly 
compact structure, as a broader range of FRET efficiencies appears to be accessible for large 
oligomers. In order to analyse the data further, the oligomers were divided into the same two 
apparent size categories described before, for direct comparison: small (2-10 monomers) and 
large oligomers (10-150 monomers); and the distribution of these two populations based on 
their FRET efficiencies was plotted over time (Figure 5.3). For small oligomers, only one 
Gaussian-like distribution is observed, and the number of oligomers increases within the first 
2 h.  This number then decreases over time until reaching its lowest point after 12 h (Figure 
5.3, a). Very few large oligomers are detected at any time and their FRET efficiencies do not 
follow any trend in distribution (Figure 5.3, b). The histograms for the small population are 
shown for a clearer visualisation in Figure 5.4. To further investigate the differences in the 
evolution of the small oligomer populations in the absence and in the presence of clusterin over 
time, the oligomer distributions were fitted to a sum of two Gaussian distribution curves, whose 
centres and widths were fixed and equal to those used in Chapter 4 (with centres at 0.34, 0.60 
and widths equal to 0.217, 0.202, for low-FRET and high-FRET oligomers, respectively, Eq. 
4.1 and 4.2). The same centres were chosen as it is unlikely that the FRET efficiencies shown 
by the Alexa fluorophores would be affected by the presence of clusterin, due to the former 
being hydrophilic in nature whilst the latter is hydrophobic, and therefore the dielectric 
environment of the dye is not likely to be affected. In addition, when fitted to one-peak 
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Gaussian curves without any set boundaries, the average FRET efficiency for the centre of the 
population distribution for all time points is equal to 0.57 ± 0.01, which is comparable to that 
found for the small high-FRET population in Chapter 4. Therefore, we believe the direct 
comparison is feasible for the purpose of this analysis, in order to provide insights into the 
mechanisms by which clusterin is perturbing said distributions. The amplitude of each of the 
Gaussian curves was used to calculate the fraction of the low-FRET and high-FRET 
populations for each time point and then plotted over time (Figure 5.5). The fraction of the 
small low-FRET oligomers remains constant and equal to 0.15-0.20 over time (Figure 5.5, a). 
Thus, the fraction of the high-FRET population also remains constant over time (0.80-0.85) 
(Figure 5.5, b). In comparison, the fraction of the low-FRET population in the absence of 
clusterin shows a clear decrease throughout the aggregation (Figure 5.5, a), whereas the 
fraction of the high-FRET population increases over time (Figure 5.5, b). No significant 
amounts of large oligomers are detected in the presence of clusterin (Figure 5.5, c). Finally, the 
distributions of the oligomer population for each time point were fitted to one-peak Gaussian 
curves without any constraints on their centre or width, and the centres obtained after the fitting 
were plotted against time. The result shows that the population distribution remains constant 
and centred at a FRET efficiency of ~0.6 for all the analysed time points in the presence of 
clusterin, whereas the same fitting process shows an increase in the FRET efficiency during 
the aggregation process in the absence of clusterin (Figure 5.5, d).  
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Figure 5.2. 2D plots of the size and FRET efficiencies observed for I59T HuL oligomers 
in the presence of clusterin over time. a) 0 h. b) 2 h. c) 5 h. d) 7 h. e) 9 h. f) 12 h. Size does 
not appear to increase over time. The FRET efficiency for both small and large oligomers spans 
from 0.2-0.8. 
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Figure 5.3. Evolution of oligomer populations over time. The oligomers are divided into two 
different apparent size categories: a) small (2-10 monomers) and b) large (10-150 monomers). 
a) For small oligomers, Gaussian-like distributions are observed and their centres are located 
at a FRET efficiency of ~0.6 for all time points after 0 h. The data for time points 0, 2, 5, 6, 7, 
9, and 12 h are shown in black, red, orange, yellow, green, cyan, and violet, respectively. The 
number of oligomers increases within the first 2 h, after which it decreases until reaching its 
minimum after 12 h. b) For large oligomers, very few events are detected. The data for time-
points 0, 2, 5, 6, 7, 9, and 12 h are shown in black, red, orange, yellow, green, cyan, and violet, 
respectively. The data show the mean and the error bars represent the standard deviation from 
three independent experiments.  
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Figure 5.4. Evolution of small oligomers over time. a) 2 h (red). b) 5 h (orange). c) 6 h 
(yellow). d) 7 h (green). e) 9 h (cyan). f) 12 h (violet). The centre of the population distribution 
is located at a FRET efficiency of ~0.6 for all time points. The number of oligomers decreases 
after 2 h. The data show the mean and the error bars represent the standard deviation from three 
independent experiments.  
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Figure 5.5. Comparison of the evolution of the low-FRET and the high-FRET oligomer 
populations of I59T HuL in the absence and in the presence of clusterin over time. a) 
Fraction of small low-FRET oligomers of I59T HuL alone (green) and in the presence of 
clusterin (blue) over time. In the presence of clusterin, the fraction of small low-FRET 
oligomers remains relatively constant at 0.15-0.20. b) Fraction of small high-FRET oligomers 
of I59T HuL alone (red) and in the presence of clusterin (orange) over time. In the presence of 
clusterin, the fraction of small high-FRET oligomers stays constant at 0.80-0.85. c) Number of 
large low-FRET and high-FRET oligomers over time where low-FRET oligomers are shown 
in green and blue in the absence and in the presence of clusterin, respectively, and the high-
FRET oligomers are shown in red and in orange in the absence and in the presence of clusterin, 
respectively. In the presence of clusterin, the number of large low-FRET and high-FRET 
oligomers are virtually zero. d) Change in the FRET efficiency centre of the population 
distributions over the course of the aggregation time-course. The oligomer populations for each 
time point were fitted to a one-peak Gaussian curve and their centres were then plotted over 
time in the absence (black) and presence (pink) of clusterin. In the presence of clusterin, the 
FRET efficiency of the distribution centres remains constant at ~0.6 throughout the course of 
the aggregation. The data show the mean and the error bars represent the standard deviation 
from three independent experiments.  
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5.3. Conclusion and next steps 
 
In this chapter we explored the interaction of clusterin with I59T HuL oligomers under 
physiologically relevant conditions using SM FRET. The results showed significant 
differences in the oligomer population distributions in the presence and absence of clusterin 
and hence this confirms that clusterin does interact with HuL oligomers during the course of 
aggregation. In the presence of clusterin, only one population of small oligomers (apparent size 
of 2-10 monomers) is detected, of which high-FRET oligomers account for 80-85%. For this 
reason, the two-peak fitting used for I59T alone is no longer viable and a one-peak Gaussian 
curve fitting describes the data more accurately. In addition, this oligomer population is present 
at a FRET efficiency centred at 0.6, which is corresponding to the small high-FRET oligomers 
present later in the aggregation process of I59T in the absence of clusterin. This data therefore 
suggests that clusterin may be promoting the conformational change of small oligomers from 
the low-FRET to the high-FRET species and then trapping them, consequently inhibiting the 
formation of large oligomers. At the same time, it may enhance the dissociation of small 
oligomers into monomers, as in its presence fewer small oligomers are detected. This type of 
behaviour in which clusterin traps oligomers, inhibiting further growth, has been reported 
before with respect to its interactions with amyloid-β oligomers [41, 90]. In addition, the 
interaction with low-FRET oligomers would be in agreement with the belief that extracellular 
chaperones like clusterin interact with oligomers through hydrophobic interactions, since low 
FRET efficiencies correspond to a less compact, more disorganised structure and hence, most 
likely, higher hydrophobicity [91, 179].  
 
Further analysis on the effect of clusterin on the emission properties of the donor fluorophore 
is needed as a quenching effect may lead to a reduction in the donor emission, resulting in 
apparent lower sizes and high FRET values. However, fluorescence quenching was not a 
significant factor in previous studies using A488-αS and A647-clusterin [91]. Further analysis 
would also need to be done to confirm that the small high-FRET oligomers present with 
clusterin are indeed the same oligomers observed in the absence of this chaperone, for example 
using analytical ultracentrifugation. Labelling of clusterin with A647, as done in previous 
studies [41, 90], would allow us to determine specifically which species clusterin is interacting 
with by performing SM FRET using A488-I59T HuL to follow the intermolecular interactions. 
The ability of clusterin to regulate the oligomer population distributions could be further tested 
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by adding it later in the aggregation, e.g. after 5 h, in order to see whether the dissociation of 
the oligomers into monomers or a conformational change would be promoted at that stage of 
the aggregation.  This behaviour has been observed before for the chaperone Hsp70, which has 
been found to disaggregate amyloid-β oligomers [198]. However, this behaviour is unlikely as 
the addition of clusterin later in the lysozyme aggregation process has not demonstrated fibril 
dissociation [69]. In addition, the effect of clusterin on the ability of the oligomers to produce 
cell cytotoxicity would need to be explored in order to understand the role of their interaction 
in vivo. 
 
Following the characterisation of the interaction of HuL oligomers with clusterin, investigating 
the interaction of the former with other relevant biomolecules would be paramount to explore 
more fully how the interactions with other biomolecules alter the oligomer structural properties, 
something that has been recently demonstrated for αS [91]. Other biomolecules of interest for 
the HuL system include the serum amyloid P component (SAP), which has been shown to 
inhibit the accumulation of HuL deposits in vivo [199]; and the camelid nanobody cAb-HuL5, 
which has been shown to encourage the formation of the partially-unfolded intermediate and 
yet inhibit amyloid formation [39].  
 Chapter 6: Conclusions and future work 
 
In this thesis, the species present in the early stages of the aggregation of human lysozyme were 
investigated by SM confocal microscopy.  
 
In Chapter 2, the Alexa-labelled I59T HuL was characterised by an array of biophysical 
techniques and two main conclusions could be reached from the data: first, Alexa-labelled I59T 
HuL undergoes aggregation in an equivalent manner to unlabelled I59T HuL; and second, both 
A488 and A647 are included in the fibrils and these show FRET. Therefore, these two 
conclusions confirm that Alexa-labelled I59T HuL is suitable for our SM experiments.  
 
In Chapter 3, a well-established SM microscopy set-up was optimised for the HuL system by 
using conditions in which oligomer formation is maximised.  The use of extrinsic dyes (ThT 
and pFTAA) and the techniques TCCD and SM FRET were utilised for this purpose. We were 
able to show that oligomers could be detected at micromolar and picomolar concentrations and 
the results obtained here compare well with previous characterisation of these metastable 
oligomers.  
 
In Chapter 4, the focus switched to characterising HuL oligomers formed in situ using more 
physiologically relevant conditions (pH 5.0, 60 ˚C) with the set-up optimised in Chapter 3. The 
data shows that I59T HuL first forms disordered small oligomers (apparent size of 2-10 
monomers, low-FRET). These oligomers can then undergo a conformational change to form 
more stable and structured oligomers (high-FRET). Such conformational changes have been 
shown using conventional techniques for other globular proteins such as insulin and Sso AcP 
[70, 166, 169]. This result makes sense as hydrophobic interactions can arise faster than the 
hydrogen bonds that sustain β-sheet structure can be formed. The data were then fitted to an 
early-time kinetic model, similar to those used in references [29, 42-44], and the rate of 
formation of low-FRET oligomers (α), the pseudo-rate constant of formation of high-FRET 
oligomers from low-FRET oligomers (kc), and the rate constant of dissociation of low-FRET 
oligomers (kd) were calculated. Interestingly, kd>>kc which indicates that low-FRET oligomers 
are approximately 5 times more likely to dissociate than to continue along the aggregation 
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pathway to form high-FRET oligomers. The formation of small disordered oligomers that can 
undergo a conformational change to form more structured oligomers during fibril formation 
has been previously observed for αS, tau and the yeast prion protein Ure2 [29-31, 42-44]. 
Although our data for I59T HuL shows different mechanistic dynamics to those reported for 
αS aggregation [29, 42-44], it is, in fact, in line with the studies of oligomers formed by non-
αS proteins [30, 31]. In brief, the mechanism for αS aggregation was reported to fit well to an 
early-time model with no dissociation, that is, reverse reactions were excluded from the 
analysis. The resulting model described how monomers form low-FRET efficiency oligomers 
which then convert to ordered high-FRET efficiency oligomers prior to fibril formation [29]. 
On the other hand, the model for tau described the formation of an unstable low-FRET oligomer 
population in rapid exchange with the monomeric state, and another more structured high-
FRET oligomer population, which is probably off-pathway. The disordered low-FRET 
oligomers can nucleate the formation of “fibrillar oligomers”, which can then form amyloid 
fibrils, and this nucleation can be supressed early in the reaction [31]. In the case of the yeast 
prion protein, Ure2, the proposed model involved the formation of disordered low-FRET 
oligomers, via hydrophobic interactions between native Ure2 dimers, which can then dissociate 
back to the native-state or undergo a conformational change to form more structured high-
FRET oligomers, which contain β-sheet structure, and can grow into fibrils [30]. Both tau and 
Ure2, like I59T HuL, showed the formation of these disordered low-FRET oligomers that 
predominantly dissociate but can also undergo a conformational change to form more 
structured high-FRET oligomers; and, unlike for tau, both populations have been identified as 
on-pathway to fibril formation for Ure2 and I59T HuL, as they are growth-competent and are 
most likely formed from the low-FRET oligomers later in the aggregation reaction. For I59T 
HuL, additionally, the role of high-FRET oligomers in the aggregation pathway is reinforced 
by our data in the presence of clusterin, since we showed that this population is sequestered by 
the extracellular chaperone, resulting in the inhibition of fibril formation (Chapter 5 of this 
thesis). In summary, the population of disordered low-FRET oligomers, formed from 
monomers, declines only as a consequence of the formation of a population of growth-
competent, more structured oligomers (high-FRET) for αS whereas for tau, Ure2 and I59T 
HuL, the decline in the disordered low-FRET oligomer population cannot be explained by such 
a model, as these disordered oligomers are more likely to dissociate back into monomers than 
undergo a conformational change into the more structured high-FRET oligomers. Hence, while 
the majority of Ure2, tau and I59T HuL oligomers dissociate back to monomers and do not 
ultimately form fibrils, αS oligomers remain at a significant concentration, even after all the 
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monomers are depleted [42, 200] and this behaviour is also observed for amyloid-β (1-40) 
oligomers [90]. This discrepancy between the mechanistic dynamics shown by αS and 
amyloid-β, and those observed for other disordered proteins, such as tau and Ure2, and the 
globular I59T HuL may explain, in part, the differences of these systems in disease-related 
behaviour.   
 
Finally, in Chapter 5 we investigated the interaction between HuL oligomers and clusterin, an 
extracellular chaperone which has been shown to inhibit HuL fibril formation by interacting 
with the species formed in the early stages of aggregation [69]. In the presence of clusterin, 
only small oligomers are significantly detected, of which high-FRET oligomers account for 
80-85%. This data suggests that clusterin may be promoting the conformational change from 
small low-FRET to high-FRET oligomers and trapping them, consequently inhibiting the 
formation of larger oligomers and fibrils. This result is in agreement with the literature, where 
clusterin has been shown to inhibit fibril formation of other protein systems by sequestering 
small oligomers (<15 monomers in apparent size) and preventing their growth [41, 90, 91]. In 
addition, recent research by Whiten and co-workers showed that the interactions of clusterin 
with αS oligomers are dependent on the structure of the latter, and concluded that these 
interactions were mediated by the exposed hydrophobicity on the surface of the oligomers [91]. 
Beyond clusterin, other chaperones such as α2M and Hsp70 (first introduced in this thesis in 
Section 5.1.1) have been shown to trap small oligomers of αS and tau, respectively [91, 130].  
 
The data presented in this thesis led us to revisit the aggregation pathway of human lysozyme 
and its inhibition by clusterin, that was first presented by Kumita and co-workers in 2007 [69], 
and our proposal is presented in Figure 6.1. 
 
Regarding other globular proteins, it is worth comparing human lysozyme to β2-microglobulin 
and transthyretin, first introduced in Section 1.2.2. β2-microglobulin populates an intermediate 
state that can form intermolecular interactions leading to its oligomerisation and finally 
amyloid fibrils. β2-microglobulin forms small oligomers (dimer to tetramers) that undergo 
conformational changes into more stable, less dynamic structures which can then form fibrils 
[206, 207]. This is comparable to our findings, in which I59T HuL populates more disordered 
small oligomers before undergoing a conformational change towards a more structured 
oligomer population.  
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On the other hand, the mechanism of aggregation of transthyretin consists of its dissociation 
from its native tetrameric state to an unstable monomeric state that can form intermolecular 
interactions, giving rise to small oligomers that are generally found to contain between 5-10 
monomers (Figure 1.8) [213-215, 217-219]. These oligomers are the most cytotoxic species to 
human neuroblastoma cells, whereas the fibrils formed later on are not toxic [214, 215]. It 
would be interesting to check whether this is also the case for the cytotoxicity of human 
lysozyme oligomers and fibrils. 
 
The aggregation of β2-microglobulin and transthyretin can be inhibited in the presence of 
different chaperones. The extracellular chaperone α2M interacts with the partially unfolded 
intermediate formed by β2-microglobulin, inhibiting oligomerisation and fibril formation 
[230]. The small heat shock protein αB-crystallin is also capable of inhibiting β2-microglobulin 
oligomerisation and fibril formation by competing with its self-assembly, and also enhancing 
the dissociation of β2-microglobulin oligomers back to monomers [231, 232]. In addition, 
clusterin has been shown to inhibit transthyretin aggregation by stabilising the tetrameric state 
[220], the monomeric state [209], and its oligomeric aggregation intermediates (Figure 1.8) 
[209, 221]. The latter is comparable to our findings, where clusterin interacts with lysozyme 
oligomers, increasing the population of the more stable and structured oligomeric species.  
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Figure 6.1. Proposed pathway for the aggregation of HuL and its regulation by clusterin. 
In the amyloidogenic mutational variants, the native-state stability is reduced, enhancing the 
population of a partially-unfolded intermediate. These intermediates can then interact to form 
unstable, disorganised oligomers which, in turn, can undergo a conformational change to form 
stable and structured oligomers. These oligomers will then grow to form amyloid fibrils. Our 
data shows that clusterin enhances the formation of small structured oligomers (high-FRET), 
and traps them over time, preventing them from growing into bigger aggregates. The way in 
which clusterin interacts with HuL oligomers is highlighted in pink.  
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The results shown for I59T HuL oligomers in Chapters 4 and 5 are significant as they give 
insight into the mechanistic details of fibril formation for a globular protein, as observed by 
SM microscopy techniques for the first time, thereby allowing for the comparison between 
these oligomer populations and those characterised for IDPs. In addition, these results raise 
questions that may be answered by further studies. Further insight about the degree of structural 
integrity and β-sheet content of the oligomer populations could be gained using proteinase K 
degradation coupled with SM microscopy. This method has previously shown that, for αS, the 
low-FRET oligomer population lacked a distinct structure whereas the high-FRET oligomers 
most likely contained a significant degree of β-sheet structure, albeit lower than that of the 
fibrils [42]. Interestingly, our data shows that the oligomer populations at 2 h and 9 h are quite 
defined. We therefore would like to explore whether we can see any differences in cellular 
toxicity using standard mammalian cell assays such as a MTT assay, in order to gain a better 
understanding of how these may have implications in vivo, as well as whether the oligomer 
population stabilised by clusterin alters cell viability. Additionally, A647-labelled clusterin 
could be used to further study the exact points of its interaction with I59T HuL oligomers using 
A488-labelled lysozyme.  
 
Understanding the mechanistic details by which different biomolecules, such as SAP and the 
camelid nanobody cAb-HuL5, regulate HuL fibril formation, and how these differ from those 
seen for clusterin, will be needed to further understand how the different stages of the 
aggregation pathway can be modulated. In addition, in order to understand the role of these 
oligomer populations in vivo, it would be imperative to prove their toxicity in cells and 
investigate whether this toxicity is attenuated in the presence of clusterin or other biomolecules, 
as shown for other systems in the literature [91, 179]. 
 Chapter 7: Materials and methods 
 
7.1. Characterisation of the native-state of human lysozyme 
 
This section will cover the material and methods used to characterise the monomeric state of 
unlabelled and fluorescently labelled HuL.  
 
7.1.1. Expression and purification of human lysozyme in Pichia pastoris  
 
Pre-cultures (10mL) of YPD medium (1% yeast extract, 2% peptone, 2% dextrose) were 
inoculated with Pichia pastoris cells containing the human lysozyme gene for each variant. 
After incubation for 48 h (230 rpm, 30 ˚C), these cultures were used to inoculate buffered 
minimal glycerol media (BMG; 400 mL, 100 mM potassium phosphate pH 6.0, 1.34% yeast 
nitrogen base, 4 x 10-5% biotin, 1% glycerol). After growing to a high density (48 h, 230 rpm, 
30 ˚C), the cultures (200 mL) were centrifuged at 5000 x g (5 min, 4 ˚C) in a Beckman Avanti 
J centrifuge (Beckman Coulter Inc., Buckinghamshire, UK) in autoclaved 500 mL centrifuged 
pots. The supernatant was removed and the pellets were re-suspended in buffered minimal 
methanol media (BMM; 400 mL, 100 mM potassium phosphate pH 6.0, 1.34% yeast nitrogen 
base, 4.0 x 10-5% biotin, 0.5% methanol) and incubated for 96 h (230 rpm, 23 ˚C) with the 
0.5% methanol being replenished every 24 h. After incubation, the cultures were centrifuged 
(10 min, 5000 x g, 4 ˚C), and the pellets discarded. The supernatant was then centrifuged a 
second time (10 min, 5000 x g, 4 ˚C) and filtered with a 0.45 µm filter (Durapore membrane 
filters, Merck-Millipore, Hertfordshire, UK). Purification of lysozyme from the supernatant 
was performed on a HS20 cation-exchange POROS column (Applied Biosystems, Warrington, 
UK) on an ÄKTA Pure system (GE Healthcare, Little Chalfont, UK). Lysozyme was eluted at 
~55 mS via a linear sodium chloride gradient. The protein peaks were analysed by SDS-PAGE 
on a 4-12% Bis-Tris NuPAGE gels (Life Technologies, Paisley, UK) using MES running buffer 
under reducing conditions, and the relevant fractions were dialysed using a 3.5 kDa MWCO 
membrane (Spectra/Por dialysis membrane, standard RC tubing, Spectrum Laboratories, 
Repligen Corporation, Massachusetts, USA) against water for 48 h and then lyophilised. The 
purity of the protein was confirmed by SDS-PAGE and molecular masses were determined by 
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MALDI mass spectrometry. The concentration of HuL was determined on a NanoDrop 2000c 
spectrophotometer (Labtech International Ltd., Uckfield, UK) using an extinction coefficient 
of 37,485 M-1 cm.1 (Abs280 = 2.55 for a 1 mg mL
-1 protein solution).  
 
7.1.2. Characteristics of the fluorophores 
 
The spectral properties of the fluorescent dyes used in this thesis are shown is Table 5. 
 
Table 5. Spectral properties of the fluorophores  
Property  /  Dye 
Fluorescein 
derivative 
A488 A647 
Mw (gmol-1) 473.39 643.4 842.02 
Extinction coefficient, ε (cm-1M-1) ~70,000 73,000 270,000 
Excitation wavelength, λmax (nm) 492 494 651 
Emission wavelength, λmax (nm) 520 517 672 
*Lifetime (ns) 4.1 4.1 1 
**Quantum yield (ϕ) ~0.95 0.92 0.33 
*Lifetime measurements were made in water at 22˚C, data provided by ISS Inc. (Champaign, 
IL). **Quantum yield measurements for the Alexa dyes were made in PBS (50 mM potassium 
phosphate, 150 mM NaCl, pH 7.2) at 22˚C relative to fluorescein in 0.01 M NaOH, data 
provided by ThermoFisher (Thermo Fisher Scientific, Waltham, Massachusetts, USA).   
 
7.1.3. Fluorescent labelling of HuL 
 
Human lysozyme (HuL, 6.8 µM) was dissolved in MES buffer (100 mM) in pH 5.0 for the 
A647 succinimidyl ester derivative and pH 8.0 for the fluorescein and A488 succinimidyl ester 
derivatives with stirring in a glass vial (3 mL). The fluorescein derivative and the Alexa 
fluorophores succinimidyl ester derivatives were dissolved in DMSO (1 mg in 300 μL) and the 
dye concentrations were determined using UV-vis absorbance at the corresponding excitation 
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wavelength for each fluorophore on a NanoDrop 2000c spectrophotometer (Labtech 
International Ltd.). Samples were incubated for 18 h with stirring (1000 rpm) at 50 ˚C for the 
fluorescein derivative and at 45 ˚C for the Alexa dyes derivatives. The buffer was exchanged 
to de-ionised water after 24 h using centrifuge cut-off filters (3 kDa) (GE Healthcare) before 
purification (Section 7.1.4).  
 
7.1.4. Purification of labelled HuL   
 
The end points of the reaction were dissolved in 50 mM Tris buffer, pH 8 and purified using a 
monoS ion exchange column (GE Healthcare) on an ÄKTA Pure purification system (GE 
Healthcare). The protein was eluted using a sodium chloride (NaCl) gradient (0-1.5 M). The 
buffer of the fractions containing the desired product was exchanged to de-ionised water using 
centrifuge cut-off filters (3 kDa) (GE Healthcare). The protein integrity and purity were 
confirmed by mass spectrometry by Dr. Janet Kumita using Electrospray mass spectrometry 
on a Xevo G2 mass spectrometer (Waters UK, Elstree, Hertfordshire, UK) within the mass 
spectrometry facilities at the Dept. Chemistry, University of Cambridge.  The concentration of 
the sample was determined on a NanoDrop 2000c spectrophotometer (Labtech International 
Ltd.) using the extinction coefficients of the corresponding fluorophores (Table 5), and then 
flash-frozen in aliquots with liquid nitrogen and stored at -20 ˚C until further use. The 
molecular masses of labelled HuL are shown in Table 6. 
 
Table 6. Molecular weight of labelled HuL 
Sample Label 
MW (Da) of the 
fluorophore 
MW (Da) of singly-labelled HuL 
F-WT HuL F-NHS 473.39 15166 
F-I59T HuL F-NHS 473.39 15154 
A488-I59T HuL A488 516.47 15198 
A647-I59T HuL A647 842.02 15523 
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7.1.5. SDS-PAGE analysis of Alexa-labelled HuL 
 
Polyacrylamide gel electrophoresis (SDS-PAGE) analysis of labelled HuL was done on a 4-
12% Bis-Tris NuPAGE gels (Life Technologies) using MES running buffer under reducing 
conditions. The gels were then imaged on a Typhoon Trio Variable Mode Imager System (GE 
Healthcare) measuring the fluorophore emissions after excitation at 488 and 633 nm for A488 
and A647, respectively. 
 
7.1.6. Spectroscopic characterisation of Alexa-labelled HuL 
 
The absorbance spectra of WT human lysozyme and F-WT HuL (in water) were recorded 
between 200-800 nm in a 1 cm cuvette on a Cary 400 scan spectrophotometer (Agilent Ltd., 
Oxford, UK) at room temperature.  
The excitation and emission spectra of Alexa-labelled I59T HuL were recorded in a Cary 
Eclipse spectrofluorimeter (Agilent Ltd.) at room temperature. The excitation spectra were 
recorded by setting a constant emission wavelength of 517 and 672 nm (± 5 nm slit width), 
respectively for A488-I59T and A647-I59T HuL, and recording between 250-650 nm for 
A488-I59T and 250-700 nm for A647-I59T HuL. The emission spectra were recorded using 
an excitation wavelength of 494 and 651 nm (± 5 nm slit width), respectively, and recording 
the emission between 500-650 nm for A488-I59T and 500-700 nm for A647-I59T HuL. 
 
7.1.7. Circular dichroism (CD) spectroscopy  
 
CD spectroscopy was performed on a Jasco J-810 spectropolarimeter (JASO Ltd., Great 
Dunmow, UK). Far-UV data were measured in a 0.1 cm path-length cuvette with a protein 
concentration of 13.6 µM in 0.1 M sodium citrate, pH 5, and the scans were recorded between 
215 and 250 nm. Scans were recorded at 50 nm min-1 with a 1 nm band width and a 4 s response 
time. The mean residue ellipticity (MRE) was calculated as described in reference [146]. In 
brief, the MRE at a certain wavelength (λ) is calculated as  
 
MRE = MRW × 
θλ
10
 × d × c  (Eq. 7.1) 
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where MRW is the mean residue weight, θλ is the observed ellipticity (degrees) at wavelength 
λ, d is the path length (cm), and c is the concentration (g/mL). The MRW is calculated as  
 
MRW = 
M
N - 1
  (Eq. 7.2) 
 
where M is the molecular mass of the polypeptide chain (in Da), and N is the number of amino 
acids in the chain.  
Far-UV thermal denaturation was monitored at 222 nm. During thermal denaturation, the 
temperature was increased from 20 to 95 ˚C at a rate of 0.5 ˚C min-1. Ellipticity values were 
normalised to the fraction of unfolded protein (Fu) using 
 
Fu = 
θ - θN
θU - θN
  (Eq. 7.3)  
 
where Ѳ is the observed ellipticity, ѲN is the native ellipticity and ѲU, the unfolded ellipticity. 
ѲN and ѲU were extrapolated from pre- and post-transition baselines at the relative temperature. 
Experimental data were fitted with a sigmoidal expression, using OriginPro 9.1 (OriginLab 
Corporation) where Tm is defined as the temperature where the fraction of unfolded protein is 
0.5. This method was described in detail in reference [67].  
 
7.1.8. Differential Scanning Calorimetry (DSC) 
 
The stabilities of F-WT HuL and WT HuL were investigated by measuring the heat capacity 
(Cp) as a function of temperature over the range of 15-95 ˚C/h using a VP-DSC 
MicroCalorimeter (MicroCal. LLC, Milton Keynes, UK), with protein concentrations of 7 μM. 
The baseline obtained by heating a buffer solution was subtracted from the protein sample. The 
data were fitted to a two-state model as described in reference [74],  
 
N ↔ U 
 
where N is the native-state and U is the unfolded state. The average excess heat capacity 
(<∆Cp>) was derived from the average excess enthalpy < ∆H > using the equations 
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<∆Cp> = 
∂ <∆H>
∂T
  (Eq. 7.4) 
 
<∆H> = 
∑ ( exp( - 
∑ ∆Gj
i
j=1
RT
)( ∑ ∆Hj))
i
j=1
N
i=1
1 + ∑ exp(-
∑ ∆Gj
i
j=1
RT
)Ni=1
  (Eq. 7.5) 
 
where N = 2 for a two-state model, and the enthalpy changes (∆Hj) follow the equation  
 
∆H = ∆Hm + ∆Cp (T - Tm)  (Eq. 7.6) 
 
where ∆Hm and ∆Cp are the enthalpy change at Tm, the midpoint temperature, and the heat 
capacity change of the transition, respectively.  
 
7.2. Characterisation of the fibrillar state of human lysozyme 
 
This section will cover the material and methods used to characterise the fibrillar state of 
unlabelled and fluorescently labelled HuL formed under different conditions and in the 
presence and in the absence of clusterin. 
 
7.2.1. Preparation of ThT stock solution 
 
Stock ThT solutions were prepared by dissolving ThT in phosphate-buffered saline (PBS), pH 
7.4 and then filtering through a 0.22 μm filter to give a concentration of 2.5 mM. The solutions 
were aliquoted, covered in aluminium foil, and stored at -20 ˚C until used. Once thawed, any 
ThT leftovers were discarded.  
 
7.2.2. Fibril formation of HuL under acidic conditions  
 
HuL was dissolved in 400 mM NaCl, 25 mM KH2PO4 buffer, pH 2.0. A 200 μL aliquot of the 
sample was placed in a 96-well half-area black plate, and ThT stock solution was added for a 
final concentration of 50 μM. The samples were incubated at 52 ˚C with shaking at 100 rpm 
for 5 s every 10 min in a BMG POLARstar Omega plate reader (BMG Labtech Ltd., Aylesbury, 
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UK). ThT was excited at 440 nm and its fluorescence emission was recorded at 480 nm. The 
protocol was first described in reference [153].  
 
7.2.3. Fibril formation of HuL under pH 5 conditions  
 
Alexa-labelled I59T HuL, 7 μM (3.5 μM of each dye) was incubated in a 1 cm path length 
quartz cuvette in 0.1 M sodium citrate, pH 5.0, with stirring at 60 ˚C in a Cary Eclipse 
fluorescence spectrophotometer (Agilent Ltd) and light scattering was monitored at 500 nm 
(slit width of 5 nm).  
The aggregation of unlabelled HuL was also monitored by recording ThT fluorescence in the 
presence of 62.5 µM ThT and using an excitation wavelength of 450 nm (slit width 5 nm) and 
an emission wavelength of 480 nm (slit width 5 nm).  
 
7.2.4. Fibril formation in the presence of clusterin  
 
The protocol followed here was described before by Kumita and co-workers in 2007 [69]. The 
aggregation was set-up as described in Section 7.2.3 in the presence of 1:10 clusterin-to-
lysozyme molar ratio. The clusterin was a gift from Prof. Mark Wilson at the University of 
Wollongong (Wollongong, Australia). 
 
7.2.5. Transmission electron microscopy (TEM)  
 
Fibril samples (5 µL) were collected at the endpoints of the aggregation reactions and applied 
to carbon-coated copper grids. The samples were stained with 2% (w/v) uranyl acetate, and 
imaged using a FEI Tecnai G2 transmission electron microscope (CAIC, Department of 
Physiology, Development and Neuroscience, University of Cambridge, UK). Images were 
analysed using the SIS Megaview II Image Capture system (Olympus).  
 
7.2.6. Measurement of fibril stability by guanidine thiocyanate depolymerisation 
 
Samples of HuL fibril formed under acidic conditions (100 µL) were centrifuged in a benchtop 
centrifuge (13000 rpm, 30 min, 4 ˚C) and the supernatant was removed. The fibrils were 
washed with dH2O and centrifugation was repeated (13000 rpm, 30 min, 4 ˚C), discarding the 
supernatant. The fibril pellets were re-suspended in a guanidine thiocyanate (Gdn.SCN) 
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titration of concentrations ranging 0-6 M in 0.25 M increments and incubated overnight at 25 
˚C. The samples were then centrifuged (13000 rpm, 10 min) at room temperature and the 
supernatant was saved. The concentration of monomer in the supernatant was determined by 
recording the absorbance at 280 nm for each sample and the monomer concentration was 
plotted as a function of GdnSCN concentration. These experiments were performed by 
Kimberley Callaghan.  
 
7.2.7. ThT analysis of the endpoint of aggregation 
 
Samples of fibrils formed under acidic conditions (100 μL, 350 μM) were diluted in PBS, pH 
7.4 to a total volume of 1 mL; whereas samples of fibrils formed under pH 5.0 conditions (100 
µL, 7 µM) were diluted in 0.1 M citrate buffer, pH 5.0 to a total volume of 1 mL, then 2.5% 
v/v of 2.5 mM ThT (62.5 μM) was added in both cases. ThT binding was monitored by 
excitation at 440 nm (slit width 5 nm) and recording the emission between 450 nm and 600 nm 
in a 1 mL quartz cuvette using a Cary Eclipse fluorescence spectrophotometer (Agilent Ltd.). 
The measurement of a sample with only the corresponding buffer was subtracted from all 
samples. The samples were stirred for 5 min before collecting the data. 
 
7.3. Characterisation of oligomers using conventional methods 
 
7.3.1. Dynamic light scattering (DLS)  
 
DLS measurements were performed at 25 ˚C in a Zetasizer Nano S (Malvern Instruments, 
Worchestershire, U.K.) with a Peltier temperature controller using fixed parameters (attenuator 
7, cell position 4.20 mm) using a low volume (45 μL) quartz cell with 3 × 3 mm path length.  
 
7.3.2. Atomic force microscopy (AFM) 
 
AFM was done by Ryan Limbocker, under the supervision of Dr. Simone Ruggeri, following 
the same methodology as described in [83]. 
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7.3.3. ANS measurements of time points from I59T HuL aggregation  
 
Aliquots from different time points of the 7 μM I59T HuL aggregation reaction in pH 5.0, 60 
˚C conditions were diluted in pH 5.0 buffer to 2 μM (monomer equivalents) for a total volume 
of 70 μL, where ANS was added to a final concentration of 23 μM. The emission spectra, after 
excitation at 350 nm, were recorded from 440-600 nm at room temperature in a 96-well half-
area black plate using a BMG Clariostar plate reader (BMG Labtech Ltd.). A control with only 
ANS and buffer was measured and subtracted from all samples.  
 
7.3.4. ThT measurements of time points from I59T HuL aggregation 
 
Aliquots from different time points of I59T HuL aggregation in pH 5.0, 60 ˚C conditions (100 
µL, 7 µM) were analysed following the protocol described in 7.2.6.  
 
7.4. Characterisation of oligomers using SM fluorescence microscopy  
 
7.4.1. Label-free SM fluorescence microscopy using ThT and pFTAA as extrinsic dyes 
 
The preparation of ThT stocks solutions was described in Section 7.2.1. The pFTAA stock 
solutions were prepared in 25 mM Tris buffer, 100 mM NaCl, pH 7.4, as described in reference 
[134]. The concentrations of the extrinsic dyes for the SM microscopy experiments were 
optimised [134] and, in this thesis, 0.5 μM and 5 μM of ThT were used for the pH 5.0 and pH 
2.0 conditions, respectively, whereas 30 nM of pFTAA was used for both conditions.  
The methodology for these experiments is described in detail in reference [134]. Briefly, 
aliquots of different time points were taken during I59T HuL aggregation and diluted to 
micromolar concentrations in the corresponding buffer (10 and 1 μM for the aggregation under 
acidic conditions and the pH 5.0 conditions, respectively) and one of the extrinsic dyes for a 
final concentration of ThT of 5 μM (acidic conditions) and 0.5 μM (pH 5.0 conditions) and 30 
nM of pFTAA. The samples were then injected into the microfluidic device described in 
Section 1.5.4, and infused at a flow rate of 0.61 cm s-1 as controlled by a syringe pump (Harvard 
Apparatus PhD Ultra, Cambridge, UK) attached to the outlet port via Fine BorePolyethylene 
Tubing (0.38 mm inner-diameter, 1.09 mm outer-diameter; Smiths Medical International, 
Hythe, Kent, UK). A 488 nm laser (1.5 mW, OFL68, OdicForce) was used for the excitation 
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of the sample by directing it onto the back aperture of an inverted microscope (Nikon Eclipse 
TE2000-U, Nikon Ltd., Kingston upon Thames, UK). The beam was focused through an 
objective (Apochromat 60X, NA 1.40, Nikon) by reflection on a dichroic mirror (Di01-
R488/543/594, Laser 2000),  to a concentric spot with limited diffraction, 10-15 μm into the 
sample being flown through a channel of the microfluidic device. The fluorescence from the 
sample was collected with the same objective, reflected into the same dichroic mirror, and 
passed through a 50 μm pinhole (Melles Griot) to remove any out-of-focus light. The emission 
was filtered (FF01−510/84) and directed to an avalanche photodiode (APD, SPCM-14, Perkin-
Elmer Optoelectronics). A field-programmable gate array (FPGA, Colexica), was used to 
detect the signals from the detectors and transform these into time bins, which were selected 
according to the expected residence time of molecules passing through the confocal volume. 
At each time point, data were collected for 10 min (100,000 time bins, bin width 0.2 ms). The 
experimental output data were collected by use of an FPGA card and analysed in Igor Pro 7 
(version 7.0.2.2 64-bit) by use of customised code written by Dr. Mathew Horrocks. The code 
only accounts for bursts that show higher photon counts than an applied threshold, which was 
selected as described in Section 1.5.2, and then calculates the total number of events, the total 
intensity, and the average intensity for each time point.  
 
7.4.2. SM microscopy using Alexa-labelled HuL 
 
The Alexa-labelled I59T HuL and the SM microscopy set-up described in Section 1.5.4 were 
used following the methods described before in detail [43, 121]. The methodology described 
in Section 7.4.1 applies for the labelled experiments with the difference of the use of two 
overlapping beams, at 488 nm (OFL68, OdicForce) and at 633 nm (Melles Griot, 25LHP151, 
Cambridge, UK). In these experiments, after passing through the 50 μm pinhole, the emission 
from the samples is separated into two different channels using a second dichroic mirror 
(FF573-Di01, Laser 2000), which separates the fluorescence from the two different 
fluorophores. The longer wavelength is then focused by a lens (Plano apo convex, focal length 
= 50 mm, Thorlabs Inc., Ely, UK) through a set of filters (695AF55, Omega Optical Filters, 
Omega Optical Inc., Brattleboro, VT, USA) onto the ADP detector. The shorter wavelength is 
focused through a second set of filters (535AF55 Horiba, 540LP Omega) onto the second ADP. 
The signals from the two ADPs are connected to a customised field-programmable gate array, 
FPGA (Colexica), which combines them into time bins as described in the section above 
(7.4.1). For SM FRET experiments, only the 488 nm laser is switched on. The data were 
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analysed in Igor Pro 7 using the methodology described in Sections 1.5.2 for TCCD and in 
1.5.3 for SM FRET. The data was modelled as described in Section 4.2.5.  
 
7.4.3. Threshold selection for SM microscopy  
 
As described in Section 1.5.2, the threshold used in the data analysis of these experiments was 
determined manually. To facilitate the choice, the number of events was plotted against the 
different thresholds. The resulting graph is an exponential decay in which the sufficient 
threshold is located right before the plateau (Figure 7.1).  
 
Figure 7.1. Visualising the choice of threshold in SM experiments. The number of events 
for time point 0 h is plotted against the threshold used, resulting in an exponential decay in 
which the sufficient threshold to use is located right before the plateau (here highlighted with 
a green arrow).
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